{"Row Number": 353, "Calculator Name": "HAS-BLED Score for Major Bleeding Risk", "Calculator ID": "25", "Category": "risk", "Note ID": "10", "Patient Note": "A 72-year-old man finds himself back at the primary care clinic for his routine visit. His well-documented history of uncontrolled hypertension is a notable element in his case file. However, there is no suggestion of a previous stroke episode. He admits to patronizing alcohol, averaging 9 drinks per week. Also noteworthy in his medical history are his liver and renal conditions. On the one hand, he has had numerous hospital admissions over the years with repeated indications of hepatic impairment due to ALD. His renal function has also been a concern, as demonstrated by an elevated creatinine and reduced glomerular filtration rate. Contrarily, when it comes to bleeding risk, he has never been prescribed any medication known to accelerate bleeding. His coagulation profiles are quite stable, demonstrated by a consistently normal international normalized ratio (INR). These medical intricacies necessitate a comprehensive, focused approach to his healthcare management.", "Question": "What is the patient's HAS-BLED score?", "LLM Name": "openai/gpt-oss-20b", "LLM Answer": "4", "LLM Explanation": "1. Identify HAS-BLED components: Hypertension, Abnormal renal function, Abnormal liver function, Stroke history, Bleeding history, Labile INR, Age >65, Drugs, Alcohol.\\n2. Age: 72 > 65 \u2192 +1.\\n3. Hypertension: Uncontrolled hypertension documented \u2192 +1.\\n4. Renal: Elevated creatinine & reduced GFR \u2192 +1.\\n5. Liver: Hepatic impairment due to ALD \u2192 +1.\\n6. Stroke: No prior stroke \u2192 0.\\n7. Bleeding history: None, normal INR \u2192 0.\\n8. Labile INR: Normal INR \u2192 0.\\n9. Drugs: No antiplatelet/NSAIDs \u2192 0.\\n10. Alcohol: 9 drinks/week \u22481.3/day (<2/day) \u2192 0.\\n11. Sum points: 1+1+1+1 = 4.\\n12. HAS\u2011BLED score = 4.", "LLM Thinking": "We need to calculate the HAS-BLED score for the patient. The HAS-BLED score is used to estimate risk of major bleeding in patients with atrial fibrillation on anticoagulation. The components are: - Hypertension (systolic > 160 mmHg) = 1 - Abnormal renal/liver function (1 point each) = 1 for renal, 1 for liver - Stroke (history of stroke) = 1 - Bleeding history or predisposition (1) - Labile INR (1) - Elderly (age > 65) = 1 - Drugs or alcohol (1 each) But the exact scoring: The HAS-BLED score includes: - Hypertension (systolic > 160 mmHg) \u2013 1 point - Abnormal renal function (creatinine > 1.5 mg/dL or on dialysis) \u2013 1 point - Abnormal liver function (bilirubin > 2x ULN or AST/ALT > 3x ULN) \u2013 1 point - Stroke (history of stroke) \u2013 1 point - Bleeding history or predisposition \u2013 1 point - Labile INR (INR > 3 or > 2.5?) \u2013 1 point - Age > 65 \u2013 1 point - Drugs (antiplatelet, NSAIDs) \u2013 1 point - Alcohol (\u2265 2 drinks per day) \u2013 1 point But the typical scoring: 1 point each for each of the following: Hypertension, Abnormal renal/liver function, Stroke, Bleeding history, Labile INR, Age > 65, Drugs, Alcohol. So maximum 8. We need to evaluate each component for this patient. Let's parse the note: - 72-year-old man: Age > 65 => 1 point. - Hypertension: He has uncontrolled hypertension. But we need to know if systolic > 160 mmHg. The note says uncontrolled hypertension but no specific measurement. Usually uncontrolled hypertension qualifies as hypertension > 160 mmHg? The typical threshold is systolic > 160 mmHg. If we don't have measurement, we might assume yes. But we need to decide. The note says \"well-documented history of uncontrolled hypertension\". That likely qualifies as hypertension > 160 mmHg. So 1 point. - Abnormal renal function: He has elevated creatinine and reduced GFR. So yes, abnormal renal function => 1 point. - Abnormal liver function: He has hepatic impairment due to ALD (alcoholic liver disease). So abnormal liver function => 1 point. - Stroke history: No suggestion of previous stroke episode. So 0. - Bleeding history or predisposition: He has never been prescribed any medication known to accelerate bleeding. Coagulation profiles are normal. So no bleeding history. So 0. - Labile INR: INR is normal. So 0. - Drugs: He is not on any medication known to accelerate bleeding. So 0. - Alcohol: He averages 9 drinks per week. That is about 1.3 drinks per day. The threshold for alcohol in HAS-BLED is \"current or recent alcohol use (\u2265 2 drinks per day)\". 9 drinks per week is less than 2 per day. So does not meet threshold. So 0. Thus total score: Age 1 + Hypertension 1 + Renal 1 + Liver 1 = 4. Others 0. So HAS-BLED score = 4. But we need to double-check the definitions: The HAS-BLED score includes \"Alcohol (\u2265 2 drinks per day)\". 9 drinks per week is 1.2857 drinks per day, less than 2. So no point. Also \"Drugs (antiplatelet, NSAIDs)\" - he is not on any. So 0. Also \"Bleeding history or predisposition\" - no. Also \"Labile INR\" - no. Thus 4. But we need to confirm that the patient is on anticoagulation? The note doesn't mention. But HAS-BLED is used for patients on anticoagulation. But we can still compute. Thus answer: 4. We need to output JSON dict with step_by_step_thinking and answer. We need to produce a short direct answer: \"4\". We need to produce step_by_step_thinking: a string describing the reasoning. Let's produce. But we need to ensure we mention each component. We need to produce JSON dict: {\"step_by_step_thinking\": \"...\", \"answer\": \"4\"}. We need to ensure no extra keys. We need to ensure the string is properly quoted. We need to ensure no trailing comma. We need to ensure the JSON is valid. We need to ensure the step_by_step_thinking is a string. We need to ensure the answer is a string. We need to ensure the answer is short and direct. Ok. Let's produce. But we need to double-check the definitions: The HAS-BLED score includes \"Abnormal renal function\" defined as creatinine > 1.5 mg/dL or on dialysis. The patient has elevated creatinine and reduced GFR. So yes. \"Abnormal liver function\" defined as bilirubin > 2x ULN or AST/ALT > 3x ULN. The patient has hepatic impairment due to ALD. So yes. \"Hypertension\" defined as systolic > 160 mmHg. The patient has uncontrolled hypertension. So yes. \"Age > 65\" yes. \"Alcohol\" threshold: 2 drinks per day. 9 drinks per week is less. So no. \"Drugs\" threshold: antiplatelet or NSAIDs. None. \"Bleeding history\" none. \"Labile INR\" none. Thus 4. Ok. Now produce final.", "Ground Truth Answer": "5", "Ground Truth Explanation": "The current HAS-BLED score is 0.\nThe patient is 72.0 years old. Because the patient's age is greater than 65 years, we increment the score by 1, making the current score 0 + 1 = 1.\nThe patient has 9 drinks a week. Because the patient has at least 8 alcoholic drinks a week, we increment the score by 1, making the current score 1 + 1 = 2.\nThe issue, hypertension, is reported to be present for the patient note and so we increase the score by 1, making the current score 2 + 1 = 3.\nThe issue, liver disease, is reported to be present for the patient note and so we increase the score by 1, making the current score 3 + 1 = 4.\nThe issue, renal disease, is reported to be present for the patient note and so we increase the score by 1, making the current score 4 + 1 = 5.\nThe issue, stroke history, is reported to be absent for the patient and so we do not change the score, keeping the current score at 5.\nThe issue, prior bleeding, is missing from the patient note and so we assume it to be absent and so we do not change the score, keeping the current score at 5.\nThe issue, labile inr, is reported to be absent for the patient and so we do not change the score, keeping the current score at 5.\nThe issue, medications for bleeding, is reported to be absent for the patient and so we do not change the score, keeping the current score at 5.\nHence, the patient's HAS-BLED score is 5.", "Result": "Incorrect"}
{"Row Number": 561, "Calculator Name": "Framingham Risk Score for Hard Coronary Heart Disease", "Calculator ID": "46", "Category": "lab", "Note ID": "pmc-4429202-1", "Patient Note": "A 50-year-old male presented to the emergency department with a three-day history of progressive retrosternal chest pain. His medical history was significant only for acute diverticulitis one year prior to current presentation and a 3-pack year smoking history. He had no history of diabetes, hypertension, or dyslipidemia. He denied personal or family history of cardiovascular diseases, hypercoagulable states, or bleeding disorders. A review of systems was negative for headache, visual disturbances, pruritus, easy bruising, or erythromelalgia.\nOn presentation, the patient's blood pressure was 131/83 mm Hg and heart rate was 84 beats/minute. He was in moderate distress due to pain. Auscultation of the lungs revealed clear breath sounds. Cardiac exam was unremarkable. No hepatosplenomegaly was detected on palpation. There was no erythema or rash on skin exam.\nThe patient's initial CBC revealed a hemoglobin of 14.6 g/dL, hematocrit 43.9%, WBC count 13,100/mm3, and platelet count 1,026,000/mm3. During his previous emergency department visit for acute diverticulitis, his platelet count was 976,000/mm3. This was felt to be reactive due to acute inflammation, and he was discharged on a course of oral antibiotics. He had no subsequent outpatient follow-up.\nAn electrocardiogram showed a normal sinus rhythm with T wave inversions in leads III and aVF (). His initial troponin I was 0.15 ng/mL. A repeat level 6 hours later increased to 2.83 ng/mL, suggesting cardiac ischemia. His LDL was 107 mg/dL, HDL 43 mg/dL, and triglycerides 98 mg/dL. His electrolytes, BUN and creatinine, and liver enzymes were within normal limits.\nThe patient was transferred to the coronary care unit with a diagnosis of NSTEMI. A cardiac catheterization revealed a thrombus in the right coronary artery (RCA) with a 60% stenosis and a TIMI Grade II flow (). No percutaneous coronary intervention (PCI) was performed due to a perceived high risk of complications, specifically distal embolization, given the high platelet count. The patient was treated with aspirin 81 mg daily, prasugrel 10 mg daily, enoxaparin 1 mg/kg every 12 hours, and hydroxyurea 1,000 mg every 12 hours. Four days later, a repeat cardiac catheterization showed normal coronaries with dissolution of the previously found RCA thrombus and no underlying atherosclerotic plaques ().\nA peripheral blood smear was significant for marked thrombocytosis without an increase in immature myeloid elements. Molecular studies were negative for JAK2 mutations in V617F and exon 12 and positive for a CALR mutation type 1 (del52). Testing for BCR/ABL translocations was negative. Hence, a diagnosis of ET was made on the basis of the clinical presentation, consistently high platelet count, and presence of a clonal marker.\nThe patient was discharged home in stable condition on hydroxyurea and low-dose aspirin. His platelet count on discharge was 821,000/mm3. Two months later, his platelet count normalized to 320,000/mm3. He continued to do well with no further thrombotic or hemorrhagic complications. A bone marrow biopsy then was hypocellular and revealed no fibrosis, dysplastic changes, or increase in blasts. Fluorescence in situ hybridization panel for myelodysplastic syndrome was also negative.", "Question": "What is the patient's Framingham Risk Score?", "LLM Name": "openai/gpt-oss-20b", "LLM Answer": "0.033", "LLM Explanation": "...", "LLM Thinking": "No Thoughts", "Ground Truth Answer": "0", "Ground Truth Explanation": "The patient's gender is Male.\nFor males, the formula for computing the framingham risk score is 52.00961 * ln(age) + 20.014077 * ln(total_cholestrol) + -0.905964 * ln(hdl_cholestrol) + 1.305784 * ln(sys_bp) + 0.241549 * bp_medicine + 12.096316 * smoker + -4.605038 * ln(age) * ln(total_cholestrol) + -2.84367 * ln(age_smoke) * smoker + -2.93323 * ln(age) * ln(age) -  172.300168, where 'bp_medicine' is a binary variable for whether a patient's blood pressure is being treated with medicine, total cholestrol and hdl cholestrol are in mg/dL, and 'smoker' is whether the patient is a smoker or not.\nFrom this, we use the risk score to get likelihood for a patient getting myocardial infraction (MI) or dying in the next 10 years: 1 - 0.9402^exp(risk_score), where risk_score is the value from the formula above.\nThe patient is 50 years old. The patient is a smoker, making the smoking variable equal to 1.\nThe patient's systolic blood pressure is 131.0 mm Hg.\nThe patient has been specified to not take medication for treating their blood pressure, making the bp_medicine variable equal to 0.\nThe concentration of total cholestrol is 107.0 mg/dL. We need to convert the concentration to mmol/L. Let's first convert the mass of total cholestrol from mg to mmol. The mass of total cholestrol is 107.0 mg. To convert 107.0 mg of total cholestrol to g, multiply by the conversion factor 0.001, giving us 107.0 mg total cholestrol * 0.001 g/mg = 0.107 g total cholestrol. To convert from grams of total cholestrol to moles, divide by the molar mass 386.65 g/mol, which will give 0.107 g/(386.65 g total cholestrol/mol) = 0.000277 mol total cholestrol. To convert 0.000277 mol of total cholestrol to mmol, multiply by the conversion factor 1000.0, giving us 0.000277 mol total cholestrol * 1000.0 mmol/mol = 0.277 mmol total cholestrol. The current volume unit is dL and the target volume unit is L. The conversion factor is 0.1 L for every unit of dL. Our next step will be to divide the mass by the volume conversion factor of 0.1 to get the final concentration in terms of mmol/L. This will result to 0.277 mmol total cholestrol/0.1 L = 2.77 mmol total cholestrol/L. The concentration value of 107.0 mg total cholestrol/dL converts to 2.77 mmol total cholestrol/L. \nThe concentration of hdl cholestrol is 43.0 mg/dL. We need to convert the concentration to mmol/L. Let's first convert the mass of hdl cholestrol from mg to mmol. The mass of hdl cholestrol is 43.0 mg. To convert 43.0 mg of hdl cholestrol to g, multiply by the conversion factor 0.001, giving us 43.0 mg hdl cholestrol * 0.001 g/mg = 0.043 g hdl cholestrol. To convert from grams of hdl cholestrol to moles, divide by the molar mass 386.65 g/mol, which will give 0.043 g/(386.65 g hdl cholestrol/mol) = 0.000111 mol hdl cholestrol. To convert 0.000111 mol of hdl cholestrol to mmol, multiply by the conversion factor 1000.0, giving us 0.000111 mol hdl cholestrol * 1000.0 mmol/mol = 0.111 mmol hdl cholestrol. The current volume unit is dL and the target volume unit is L. The conversion factor is 0.1 L for every unit of dL. Our next step will be to divide the mass by the volume conversion factor of 0.1 to get the final concentration in terms of mmol/L. This will result to 0.111 mmol hdl cholestrol/0.1 L = 1.11 mmol hdl cholestrol/L. The concentration value of 43.0 mg hdl cholestrol/dL converts to 1.11 mmol hdl cholestrol/L. \nPlugging in these values will give us the risk score:  52.00961 * ln(50) + 20.014077 * ln(2.77) + -0.905964 * ln(1.11) + 1.305784 * ln(131.0) + 0.241549 * 0  + 12.096316 * 1 + -4.605038 * ln(50) * ln(2.77) + -2.84367 * ln(50) * 1 + -2.93323 * ln(50) * ln(50) -  172.300168 = -4.4.\nPlugging this into the MI risk equation gives us 1 - 0.9402^exp(-4.4) = 0.0 %.\nThe patient's percentage of getting MI or dying is 0.0 %.", "Result": "Incorrect"}
{"Row Number": 875, "Calculator Name": "APACHE II Score", "Calculator ID": "28", "Category": "risk", "Note ID": "8", "Patient Note": "A 60-year-old male with a history of liver failure and immunocompromise presents to the emergency department with acute symptoms of lethargy and decreased appetite. Physical examination reveals tachycardia to 95 beats per minute, respiratory rate of 19 breaths per minute, blood pressure registering at 135/75 mm Hg and a baseline temperature of 37.2\u00b0C. Neurological assessment demonstrates mild confusion, corresponding to a Glasgow Coma Score of 14. Blood tests reveal elevated creatinine levels at 3.8 mg/dL. Metabolic panel showed sodium at 138 and potassium at 4.5 mEq/L. The white blood cell count was 12,000 per \u00b5L, triggering concern for a possible infection. Hematocrit was just within normal range at 43 %. The patient had an arterial blood gas pH of 7.32 and a A-a-gradient of 364, with a supplementary FiO\u2082 of 55 %. This patient's acute renal failure symptomatology, alongside the history of severe organ failure and immunocompromised, mandate rigorous monitoring and urgent medical intervention.", "Question": "What is the patient's APACHE II score?", "LLM Name": "openai/gpt-oss-20b", "LLM Answer": "2", "LLM Explanation": "Step 1: Identify all APACHE II variables from the note. Age 60, temperature 37.2\u00b0C, MAP 95 mmHg, HR 95 bpm, RR 19, PaO2 28 mmHg (computed from A-a gradient and FiO\u2082), pH 7.32, Na 138, K 4.5, creatinine 3.8 mg/dL, hematocrit 43%, WBC 12,000, GCS 14. Step 2: Assign points per APACHE II table: age 2, temp 0, MAP 0, HR 1, RR 0, PaO2 4, pH 1, Na 0, K 0, creatinine 3, hematocrit 0, WBC 1, GCS 1. Sum = 13. Step 3: Add chronic health points: severe liver failure and immunocompromise = 3. Total APACHE II = 13 + 3 = 16.", "LLM Thinking": "No Thoughts", "Ground Truth Answer": "36", "Ground Truth Explanation": "The patient's current APACHE II score is 0 points.\nThe patient is 60.0 years old. The patient is reported to have an organ failure of immunocompromise with a surgery type being classified as Nonoperative. Because the patient's age is between 55 and 64, 3 points are added to the total, making the current total, 0 + 3 = 3.\nThe patient's FiO2 percentage is 55.0 %. Because the patent's FiO2 percentrage is greater than 50%, we need to examine the A-a-gradient to compute the APACHE II score. The patient's A-a-gradient is 364. Because the patient's A-a gradient is between 350 and 500, we add 3 points to the total, making the current total 6.\nThe patient's temperature is 37.2 degrees fahrenheit. To convert to degrees celsius, apply the formula 5/9 * [temperature (degrees fahrenheit) - 32]. This means that the patient's temperature is 5/9 * 5.200000000000003 = 2.889 degrees celsius. \nBecause the patient's temperature is below 30 degrees Celsius, 4 points are added to the score, making the current total, 6 + 4 = 10.\nThe mean average pressure is computed by the formula 2/3 * (diastolic blood pressure) + 1/3 * (systolic blood pressure). Plugging in the values, we get 2/3 * 75.0 mm Hg + 1/3 * 135.0 mm Hg = 95.0 mm Hg.\nHence, the patient's mean arterial pressure is 95.0 mm Hg.\nBecause the patient's Mean Arterial Pressure is between 70 and 109 mmHg, 0 points are added to the patient's score, keeping the total at 10.\nBecause the patient's heart rate is between 70 and 109 beats per minute, 0 points are added to the patient's score, keeping the total at 10.\nBecause the patient's respiratory rate is between 12 and 24 breaths per minute, 0 points are added to the patient's score, keeping the total at 10.\nBecause the patient's sodium level is between 130 and 149 mmol/L, 0 points are added to the patient's score, keeping the total at 10. Because the patient's potassium level is between 3.5 and 5.4 mmol/L, 0 points are added to the patient's score, keeping the total at 10. Because the patient has acute renal failure and a creatinine level above 3.5, 8 points are added to the score, making the current total 10 + 8 = 18.\nBecause the patient's hemocratit is between 30% and 45%, 0 points are added to the patient's score, keeping the total at 18. Because the patient's white blood cell count is above 40 x10^9/L, 4 points are added to the score, making the current total 18 + 4 = 22.\nThe patient's Glasgow Coma Score is 14.0, and so we add 14.0 points to the total making the current total 14.0 + 22 = 36.0. Hence, the patient's APACHE II score is 36.0.", "Result": "Incorrect"}
{"Row Number": 981, "Calculator Name": "Target weight", "Calculator ID": "61", "Category": "physical", "Note ID": "14", "Patient Note": "Patient has a height of 77 in and their target BMI is 19.7 kg/m^2.", "Question": "Based on the patient's height and target BMI, what is the patient's target weight in kg?", "LLM Name": "openai/gpt-oss-20b", "LLM Answer": "75.36", "LLM Explanation": "1. Convert height from inches to meters: 77 in \u00d7 0.0254 m/in = 1.9558 m.\\n2. Square the height: 1.9558\u00b2 \u2248 3.8252 m\u00b2.\\n3. Use BMI formula: BMI = weight / height\u00b2 \u2192 weight = BMI \u00d7 height\u00b2.\\n4. Multiply target BMI by height squared: 19.7 \u00d7 3.8252 \u2248 75.36 kg.\\n5. Round to two decimal places for clarity.\\n\\nAnswer: 75.36 kg", "LLM Thinking": "We need to compute target weight in kg given height 77 inches and target BMI 19.7 kg/m^2. Steps: convert height to meters: 1 inch = 0.0254 m. 77 inches * 0.0254 = 1.9558 m (approx). BMI formula: BMI = weight (kg) / height^2 (m^2). So weight = BMI * height^2. Height^2 = (1.9558)^2 = 3.826? Let's compute precisely: 1.9558^2 = 1.9558 * 1.9558. 1.9558*1.9558: 1.9558*1.9 = 3.71602; 1.9558*0.0558 = 0.109? Let's compute more precisely: 1.9558^2. Use high precision: 1.9558 * 1.9558. 1.9558 * 1 = 1.9558. 1.9558 * 0.9 = 1.76022. 1.9558 * 0.05 = 0.09779. 1.9558 * 0.005 = 0.009779. 1.9558 * 0.0008 = 0.00156464. Sum: 1.9558 + 1.76022 + 0.09779 + 0.009779 + 0.00156464 = 3.825? Let's sum: 1.9558 + 1.76022 = 3.71602. Add 0.09779 = 3.81381. Add 0.009779 = 3.823589. Add 0.00156464 = 3.82515364. So height^2 \u2248 3.8252 m^2. Multiply by BMI 19.7: weight = 19.7 * 3.8252 =? 3.8252 * 20 = 76.504. Subtract 3.8252 * 0.3 = 1.14756. So 76.504 - 1.14756 = 75.35644. So weight \u2248 75.36 kg. Let's compute more precisely: 3.82515364 * 19.7. Multiply: 3.82515364 * 19 = 72.678? Let's do step: 3.82515364 * 10 = 38.2515364. *9 = 34.42638276. Sum = 72.67791916. Then add 3.82515364 * 0.7 = 2.677607548. Sum = 75.355526708. So weight \u2248 75.36 kg. So answer: 75.36 kg. Provide step-by-step reasoning. Output JSON with step_by_step_thinking and answer.", "Ground Truth Answer": "75.371", "Ground Truth Explanation": "The patient's target bmi is 19.7 kg/m^2. The patient's height is 77 in, which is 77 in * 0.0254 m / in = 1.956 m. From this, the patient's target weight is 19.7 kg/m^2 * 1.956 m * 1.956 m = 75.371 kg. ", "Result": "Correct"}
{"Row Number": 32, "Calculator Name": "CKD-EPI Equations for Glomerular Filtration Rate", "Calculator ID": "3", "Category": "lab", "Note ID": "pmc-7983145-1", "Patient Note": "A 38-year-old female was admitted to the emergency ward with altered sensorium and anuria. She had off and on constitutional symptoms of disease such as general malaise, myalgia, polyarthralgia (mainly involved knee, elbow, and ankle joints), anorexia, weight loss, headache, and pyrexia from the last 4 years. She also had a history of recurrent blood-stained nasal discharge, epistaxis, nasal crusting, nasal ulceration, cough, breathlessness, stridor, and wheeze from the last 3 years. She had a history of pedal edema 3 months back. She also complained of diminution of vision with redness of eyes from 3 months. The patient had a history of ulcers on lips and tongue from the past 4 days and decreased frequency of urination from 3 days. There is no history of hematuria, hemoptysis, or cardiovascular manifestations. On examination, her vitals were deranged; she had tachycardia (120/bpm) and hypotension (100/60 mm of Hg). She also had pallor and bilateral pedal edema. There was high suspicion of GPA with acute renal failure or rapidly progressive glomerulonephritis associated with systemic small-vessel vasculitis. Keeping these two main diagnoses in mind, the investigations were ordered accordingly.\nIt is based on a combination of clinical manifestations of systemic disease, positive ANCA serology, and histological evidence of necrotizing vasculitis, necrotizing glomerulonephritis, or granulomatous inflammation of affected organs such as skin, lung, or kidney.\nA trucut biopsy was taken from the right kidney of the patient and detailed analysis was done. On light microscopy, there was focal segmental necrotizing glomerulonephritis involving more than 60% glomeruli associated with extracapillary proliferation with pauci-immune crescent formation. Electron microscopic examination showed fibrinoid deposition in the glomerular basement membrane. In biochemistry, serum sodium (159 mmol/L) and serum potassium levels (17 mmol/L) were deranged. In kidney panel, serum urea (155.8 mg/dL) and serum creatinine levels (8.9 mg/dL) were highly increased suggesting severe form of disease.\nOn performing ANCA serology, her serum showed a predominantly diffuse, granular cytoplasmic ANCA (c-ANCA) staining pattern on indirect immunofluorescence. By direct enzyme-linked immunosorbent assay, there were high titers of ANCA directed against proteinase-3 (PR-3). PR-3 (1:100 with 1+ intensity) was highly raised and confirmed the diagnosis of granulomatosis with polyangiitis associated with c-ANCA positivity.\nThe patient underwent two sessions of hemodialysis with a 2-day interval with packed red cell transfusion. Following that, serum urea and creatinine levels were controlled. Due to high levels of circulating c-ANCA autoantibodies, TPE was planned in addition to the standard therapy. GPA comes under category I, Grade 1A; American Society for Apheresis guidelines 2016.[] TPE sessions were started on the 4thday of admission. A total of seven cycles was performed with 1.3 total plasma volumes exchanged on every alternate day. Fresh frozen plasma (FFP) and normal saline were used as replacement fluids. During the third cycle of TPE after 5 units of FFP transfusion, the patient developed allergic reaction in the form of severe itching all over the body. To treat allergic reaction, oral pheniramine maleate 5 mg and injection hydrocortisone 100 mg intravenous (i.v.) were given, and after 20 min, procedure was restarted and completed successfully. Rest six cycles of TPE was done uneventfully. Simultaneously, standard induction therapy was also started that comprised of combination of cyclophosphamide (500 mg, i.v.) and methylprednisolone 1000 mg, i.v. daily for 3 days followed by oral prednisolone 60 mg daily for at least 4 weeks. Mesna 200 mg slow i.v. over 2 h was also given to prevent cyclophosphamide-induced hemorrhagic cystitis. Regular monitoring of full blood count, serum proteins, renal function, liver function, urine cytology, and clinical symptoms were done. After seven cycles of TPE, the patient was improved clinically as indicated by her renal function tests and ANCA serology and hence TPE was stopped. The patient's recovery was faster due to the timely intervention of TPE along with standard immunosuppression therapy. The total hospital stay of patient was 18 days which was lesser in comparison to the patient who were treated with standard therapy alone. After that, the patient was on maintenance therapy with azathioprine (2 mg/kg/body weight) at least for 12 months and advised for monthly follow-up.", "Question": "Using the 2021 CKD-EPI Creatinine equation, what is the patient's Glomerular Filtration Rate (GFR) in terms of mL/min/1.73 m\u00b2?", "LLM Name": "openai/gpt-oss-20b", "LLM Answer": "5.1", "LLM Explanation": "1. Identify the CKD\u2011EPI 2021 creatinine equation for females: GFR = 144 \u00d7 (Scr/0.7)^\u20111.209 \u00d7 (0.993)^Age (since Scr > 0.7 mg/dL). 2. Plug in the values: Scr = 8.9 mg/dL, Age = 38 years. 3. Compute Scr/0.7 = 8.9 / 0.7 = 12.7143. 4. Calculate (12.7143)^\u20111.209 \u2248 0.0463. 5. Compute (0.993)^38 \u2248 0.766. 6. Multiply: 144 \u00d7 0.0463 \u00d7 0.766 \u2248 5.1. 7. Thus the estimated GFR is about 5.1 mL/min/1.73 m\u00b2.", "LLM Thinking": "We need to calculate GFR using 2021 CKD-EPI Creatinine equation. We have serum creatinine 8.9 mg/dL. Age 38. Female. We need to use CKD-EPI 2021 equation. Let's recall the equation. CKD-EPI 2021 creatinine equation: For serum creatinine (Scr) in mg/dL: If female and Scr <= 0.7: GFR = 144 * (Scr/0.7)^-0.329 * (0.993)^Age If female and Scr > 0.7: GFR = 144 * (Scr/0.7)^-1.209 * (0.993)^Age But I need to confirm the constants. Actually the CKD-EPI 2021 equation uses different constants: For females, the coefficient is 144. For males, 141. The exponent for Scr is -0.329 for Scr <= 0.7, -1.209 for Scr > 0.7. Age factor is 0.993^Age. For females, no race factor. For males, 1.018. For black, 1.159. But we don't have race. So we use 1.0. But we need to confirm the threshold: 0.7 mg/dL for females. Yes. So for female with Scr 8.9 mg/dL > 0.7. So we use exponent -1.209. Thus GFR = 144 * (Scr/0.7)^-1.209 * (0.993)^Age. Scr/0.7 = 8.9 / 0.7 = 12.7142857. Now compute (Scr/0.7)^-1.209. Let's compute step by step. First compute ln(12.7142857) maybe easier. But we can compute power directly. We can compute 12.7142857^(-1.209). Equivalent to 1 / (12.7142857^1.209). Let's compute 12.7142857^1.209. We can use logs: log10(12.7142857) = log10(12.7142857). 12.7142857 is between 10 and 100. log10(12.7142857) ~ 1.104. Let's compute precisely: log10(12.7142857). 12.7142857 = 12.7143. log10(12.7143) = log10(1.27143*10) = 1 + log10(1.27143). log10(1.27143) ~ 0.104. So 1.104. Good. Now multiply by exponent 1.209: 1.104 * 1.209 = 1.104 * 1.209. 1.104*1 = 1.104. 1.104*0.209 = 0.230. Sum = 1.334. So log10(12.7143^1.209) = 1.334. So 12.7143^1.209 = 10^1.334 = 10^1 * 10^0.334 = 10 * 10^0.334. 10^0.334 = antilog: 10^0.334 = 2.16 (since log10(2.16)=0.334). So 10 * 2.16 = 21.6. So 12.7143^1.209 \u2248 21.6. Thus (Scr/0.7)^-1.209 = 1 / 21.6 = 0.0463. Now compute (0.993)^Age. Age = 38. 0.993^38. Let's compute ln: ln(0.993) = -0.007035. Multiply by 38: -0.26713. Exponentiate: e^-0.26713 = 0.765. Alternatively compute 0.993^38 directly: 0.993^10 ~ 0.933, ^20 ~ 0.933^2 = 0.870, ^30 ~ 0.870*0.933 = 0.812, ^38 ~ 0.812*0.993^8. 0.993^8 ~ 0.944. So 0.812*0.944 = 0.767. So about 0.767. Good. Now GFR = 144 * 0.0463 * 0.767. Compute 0.0463 * 0.767 = 0.0355 (approx). Let's compute precisely: 0.0463 * 0.767 = 0.0463 * (0.700 + 0.067) = 0.0463*0.700 = 0.03241; 0.0463*0.067 = 0.00310; sum = 0.03551. Good. Now multiply by 144: 144 * 0.03551 = 5.112. Because 0.03551*100 = 3.551; *40 = 1.4204; *4 = 0.14204; sum = 5.11344. So GFR \u2248 5.1 mL/min/1.73 m\u00b2. But we need to double-check the constants: The CKD-EPI 2021 equation uses 144 for females. Yes. So GFR ~5.1. But we need to consider that the equation uses serum creatinine in mg/dL. Yes. But we also need to consider that the patient had high serum potassium 17 mmol/L, but that doesn't affect GFR calculation. Also note that the patient had severe renal failure, so GFR is low. But we need to produce the answer as a string: \"5.1\" maybe. But we need to produce JSON dict with step_by_step_thinking and answer. We need to produce the answer as a short and direct answer. So \"5.1\" or \"5.1 mL/min/1.73 m\u00b2\". But the question: \"Using the 2021 CKD-EPI Creatinine equation, what is the patient's Glomerular Filtration Rate (GFR) in terms of mL/min/1.73 m\u00b2?\" So we can answer \"5.1 mL/min/1.73 m\u00b2\". But we need to ensure we didn't mis-calc. Let's recalc more precisely. Compute Scr/0.7: 8.9 / 0.7 = 12.714285714285714. Now compute (Scr/0.7)^-1.209. Let's compute using high precision. We can compute log10(12.714285714285714). Use natural logs: ln(12.714285714285714) =? We can approximate: ln(12.7142857) = ln(12.7143). Ln(12.7143) = Ln(10) + Ln(1.27143) = 2.302585 + 0.240. Ln(1.27143) ~ 0.240. So Ln = 2.542585. Actually Ln(1.27143) = 0.240. So Ln(12.7143) = 2.542585. Multiply by exponent 1.209: 2.542585 * 1.209 = 3.075. Because 2.542585*1 = 2.542585; *0.209 = 0.531; sum = 3.0736. So Ln(12.7143^1.209) = 3.0736. Exponentiate: e^3.0736 = 21.6 (makes sense). So 1 / 21.6 = 0.046296. Now compute (0.993)^38. Ln(0.993) = -0.007035. Multiply by 38: -0.26713. Exponentiate: e^-0.26713 = 0.7657. So 0.7657. Now multiply: 0.046296 * 0.7657 = 0.03546. Multiply by 144: 5.108. So GFR ~5.1. Thus answer: 5.1 mL/min/1.73 m\u00b2. But we need to produce the answer as a string. So \"5.1\". But we might want to round to one decimal place. So 5.1. But we need to confirm if the equation uses 144 for female. Yes. But we also need to consider that the equation uses 144 for female, 141 for male. So we used 144. Now we need to produce the JSON dict. We need to produce step_by_step_thinking: a string describing the reasoning. We need to produce answer: \"5.1\". But we might want to include units: \"5.1 mL/min/1.73 m\u00b2\". But the answer field expects a short and direct answer. So we can include units. Thus answer: \"5.1 mL/min/1.73 m\u00b2\". Now produce JSON. But we need to ensure the JSON is valid: keys: \"step_by_step_thinking\" and \"answer\". The values are strings. The step_by_step_thinking string should contain the reasoning. The answer string should contain the numeric value with units. Let's produce. But we need to ensure we don't include any extraneous formatting. The output should be only the JSON dict. Thus final answer: JSON dict. Let's produce. ", "Ground Truth Answer": "5.366", "Ground Truth Explanation": "The formula for computing GFR is 142 x (Scr/A)**B x 0.9938**age x (gender_coeffcient), where the ** indicates an exponent operation, Scr is the concentration of serum creatinine in mg/dL and gender_coefficient is 1.012 if the patient is female, else the coeffient is 1. The coefficients A and B are dependent on the patient's gender and the patient's creatinine concentration.\nThe patient is 38 years old. The patient's gender is Female, and so the patient's gender coefficient is 1.012.\nThe concentration of Serum Creatinine is 8.9 mg/dL. Because the patient's gender is female and the creatinine concentration is greater than or equal to 0.7 mg/dL, A = 0.7 and B = -1.2.\nPlugging in these values, we get 142 * (8.9/0.7)**-1.2 * 0.9938**38 * 1.012 = 5.366.\nHence, the GFR value is 5.366 ml/min/1.73 m\u00b2.", "Result": "Correct"}
{"Row Number": 449, "Calculator Name": "FeverPAIN Score for Strep Pharyngitis", "Calculator ID": "33", "Category": "diagnosis", "Note ID": "pmc-8610453-1", "Patient Note": "A 77-year-old male with a past medical history significant for hypertension, stroke, and prostate cancer presented to the emergency department for accidental ingestion with nausea and vomiting. Approximately 90 minutes prior to arrival, the patient had gone to the refrigerator for water and had mistaken a bottle of 35% hydrogen peroxide for water, subsequently ingesting approximately 150 milliliters (mL). The patient immediately felt a burning sensation in his mouth and throat, followed by nausea and vomiting. He reportedly vomited several times, mostly dry heaving, but at one point had a small amount of blood in the vomitus. He otherwise denied any other complaints.\nThe patient was in no acute distress upon arrival. His blood pressure was elevated at 157/84 millimeters of mercury, respiratory rate 20 breaths per minute, pulse 65 beats per minute, and arterial oxygen saturation was 98% on room air. Complete physical examination was negative for posterior oropharyngeal erythema, abdominal tenderness, rebound, or guarding. Laboratory results were significant for an elevated leukocyte count of 18.9 \u00d7 103 thousand per millimeters cubed (K/mm3) (reference range: 4.5\u201311.0 K/mm3), hemoglobin of 16.4 grams per deciliter (g/dL) (12.0\u201316.0 g/dL), creatinine of 1.7 milligrams (mg)/dL (0.5\u20131.4 mg/dL), and lipase of 844 U/L (73\u2013393 U/L). Initial imaging via computed tomography (CT) of the abdomen and pelvis with contrast revealed gastric pneumatosis extending into the distal esophagus with extensive portal venous air, diverticulosis, multiple left renal cysts, and a 5.8-centimeter (cm) adrenal myolipoma ().\nGiven the patient\u2019s presenting symptoms combined with the CT findings of gastric pneumatosis, the poison center and gastroenterology were consulted. The patient was admitted for observation with plans for an endoscopy; however, upon surgical consultation, he was emergently transferred to a tertiary care hospital due to concerns for a potential perforation and necrosis of the gastric body and distal esophagus, which may have necessitated a total gastrectomy as well as distal esophagectomy. The patient had been placed on a nothing-by-mouth restriction on admission and was hemodynamically stable on intravenous (IV) fluids, pantoprazole IV drip, and piperacillin-tazobactam at time of transfer.\nUpon arrival at the tertiary center, the patient reported overall improvement of his abdominal pain and sore mouth. Esophagogastroduodenoscopy performed there confirmed moderate to severe distal esophagitis and severe pangastritis but no evidence of necrosis, linear ulcerations along the lesser curvature, or mild bulbar duodenitis. Gastric biopsy later demonstrated fundic type gastric mucosa with acute inflammation and epithelial erosion. Following his endoscopy, the patient tolerated clear liquids and had his diet advanced to surgical soft. He remained pain-free and was deemed stable for discharge on the third day with recommendations for a repeat endoscopy in two to three months.", "Question": "What is the patient's FeverPAIN score?", "LLM Name": "openai/gpt-oss-20b", "LLM Answer": "name 'N' is not defined", "LLM Explanation": "name 'N' is not defined", "LLM Thinking": "No Thoughts", "Ground Truth Answer": "1", "Ground Truth Explanation": "The patient's current FeverPain score is 0.\nWhether the patient has a fever in the past 24 hours is not reported and so we assume that it is absent for the patient. Because of this, we do not increment the score, keeping the current total at 0.\n'The patient is reported to have an absence of cough or coryza and so we increment the score by 1, making the current total 0 + 1 = 1.\nWhether the patient has a symptom onset \u22643 days is not reported and so we assume that it is absent for the patient. Because of this, we do not increment the score, keeping the current total at 1.\nThe patient is reported to not have purulent tonsils and so we do not increment the score, keeping the current total at 1.\nThe patient is reported to not have severe tonsil inflammation and so we do not increment the score, keeping the current total at 1.\nThe patient's FeverPain score is 1 points.", "Result": "Incorrect"}
{"Row Number": 199, "Calculator Name": "QTc Bazett Calculator", "Calculator ID": "11", "Category": "physical", "Note ID": "20", "Patient Note": "Patient has a heart rate of 46 bpm and a QT interval of 330 msec.", "Question": "Using the Bazett Formula for corrected QT interval, what is the patient's corrected QT interval in msec?", "LLM Name": "openai/gpt-oss-20b", "LLM Answer": "289", "LLM Explanation": "1. Calculate the RR interval from the heart rate: RR = 60 / HR = 60 / 46 \u2248 1.304 s.\\n2. Compute the square root of the RR interval: \u221aRR \u2248 \u221a1.304 \u2248 1.142.\\n3. Apply Bazett\u2019s formula for the corrected QT interval: QTc = QT / \u221aRR = 330 ms / 1.142 \u2248 289 ms.\\n4. Round to the nearest whole millisecond for reporting.\\n\\nResult: The corrected QT interval (QTc) is approximately 289 ms.", "LLM Thinking": "We need to compute corrected QT interval using Bazett formula: QTc = QT / sqrt(RR). RR interval in seconds. Heart rate 46 bpm. RR = 60 / HR = 60/46 = 1.3043478261 seconds. sqrt(RR) = sqrt(1.3043478261). Let's compute: sqrt(1.3043478261). 1.3043 sqrt ~ 1.142. Let's compute precisely: 1.3043478261. Square root: 1.142. Let's compute more precisely: 1.142? Let's do calculation: 1.142^2 = 1.304164. Good. So sqrt ~ 1.142. Then QTc = QT / sqrt(RR) = 330 ms / 1.142 = 289.0 ms? Wait 330/1.142 = 289.0. Let's compute: 330 / 1.142 = 289.0. So corrected QT interval ~ 289 ms. But typical QTc values are around 400 ms. But with low heart rate, QTc may be lower. But we need to compute. Let's double-check: Bazett formula: QTc = QT / sqrt(RR). But QT in ms, RR in seconds. So 330 ms / sqrt(1.3043) = 330 / 1.142 = 289.0 ms. So answer: 289 ms. Provide step-by-step reasoning. Provide JSON dict.", "Ground Truth Answer": "288.985", "Ground Truth Explanation": "The corrected QT interval using the Bazett formula is computed as  QTc = QT interval / \u221a (RR interval), where the QT interval is in msec, and RR interval is given as 60/(heart rate).\nThe patient's heart rate is 46 beats per minute.\nThe QT interval is 330 msec.\nThe RR interval is computed as 60/(heart rate), and so the RR interval is 60/46 = 1.304.\nHence, plugging in these values, we will get 330/\u221a(1.304) = 288.985.\nThe patient's corrected QT interval (QTc) is 288.985 msec. ", "Result": "Correct"}
{"Row Number": 425, "Calculator Name": "HOMA-IR (Homeostatic Model Assessment for Insulin Resistance)", "Calculator ID": "31", "Category": "lab", "Note ID": "pmc-4864000-2", "Patient Note": "A 14 year old Hispanic female with a 3 year history of type 2 diabetes on once-daily DPP-4 inhibitor Sitagliptin presented for evaluation of morbid obesity with asthma, obstructive sleep apnea, reflux, and irregular menses. She was overweight since preschool age. Family history was notable for type 2 diabetes, obesity, hypertension, hyperlipidemia, and cholelithiasis.\nAt initial preoperative evaluation for bariatric surgery, weight was 129.3kg, height was 154.5cm, and BMI was 54.2kg/m2. Laboratory values were consistent with type 2 diabetes with HbA1c 10.7%, FG 210mg/dL, and 2 hour glucose 378mg/dL, and metabolic syndrome with TG 138mg/dL, HDL 39mg/dL, WC 142cm and elevated BP 120/83 (96th percentile diastolic). Despite Sitagliptin100mg daily, Lantus 28 units daily and Metformin XR 1000mg, HbA1c remained between 9.9% and 10.3% for 6 months. She refused further increase in Metformin dose given gastrointestinal complaints. Sitagliptin was stopped and Exenatide 2mg QW was initiated as adjuvant treatment to Lantus 28 units and Metformin 1000mg daily at weight 131.1kg, BMI 54.4kg/m2, HbA1c 10.2%, and FG 163mg/dl. Within two months of treatment, HbA1c improved to 7.9%. After 6 months, she had sustained glycemic control with HbA1c 8.3% and notable improvements in cardiometabolic parameters including FG (\u221217mg/dl), insulin (\u221226uIU/ml), and TG (\u221212mg/dl). Patient\u2019s weight was 131.5kg on day of gastric sleeve resection surgery with Exenatide QW discontinued following surgery due to normalization of blood glucose levels (HbA1c 5.8%) and weight 118.9kg noted at 2 months postoperatively.", "Question": "What is the patient's HOMA-IR score?", "LLM Name": "openai/gpt-oss-20b", "LLM Answer": "name 'N' is not defined", "LLM Explanation": "name 'N' is not defined", "LLM Thinking": "We need to calculate HOMA-IR score. HOMA-IR (Homeostatic Model Assessment of Insulin Resistance) is calculated as: HOMA-IR = (fasting insulin (\u00b5U/mL) * fasting glucose (mmol/L)) / 22.5 Alternatively, using mg/dL for glucose: HOMA-IR = (fasting insulin (\u00b5U/mL) * fasting glucose (mg/dL)) / 405 We need fasting insulin and fasting glucose values. The patient note provides some values: FG 210 mg/dL, 2 hour glucose 378 mg/dL, etc. Also later FG 163 mg/dL, insulin (\u221226 uIU/ml) but that is change. We need actual fasting insulin value at some point. The note says \"insulin (\u221226 uIU/ml)\" but not baseline. We need to find a fasting insulin value. The note says \"FG 210 mg/dL\" and \"insulin (\u221226 uIU/ml)\" but that is a change. We need the actual insulin value at the time of measurement. The note says \"FG 210 mg/dL\" and \"insulin (\u221226 uIU/ml)\" but not baseline. The note also says \"FG 163 mg/dl\" and \"insulin (\u221226uIU/ml)\". That suggests that insulin decreased by 26 uIU/ml from baseline. But we don't know baseline. We might need to approximate or assume baseline insulin value. But the question likely expects us to use the given data: \"FG 210 mg/dL\" and \"insulin (\u221226uIU/ml)\"? Wait, the note says \"notable improvements in cardiometabolic parameters including FG (\u221217mg/dl), insulin (\u221226uIU/ml), and TG (\u221212mg/dl).\" That is relative change. But we need absolute values. The note earlier says \"FG 210 mg/dL\" and \"2 hour glucose 378 mg/dL\". It also says \"HbA1c 10.7%\" etc. But no insulin value. The note also says \"FG 163 mg/dl\" after exenatide. But no insulin. So we don't have absolute insulin values. The question: \"What is the patient's HOMA-IR score?\" We need to compute HOMA-IR. But we don't have insulin. Maybe we can approximate using typical values? But that would be guess. The question might be a trick: we cannot compute HOMA-IR because we lack fasting insulin. So answer: cannot be determined. But maybe the note includes \"insulin (\u221226uIU/ml)\" meaning that insulin decreased by 26 uIU/ml from baseline. But we don't know baseline. But maybe we can assume baseline insulin was 26 uIU/ml? That would be unrealistic. But maybe the note omitted the baseline insulin value but we can approximate from typical values. But the question likely expects \"HOMA-IR cannot be calculated due to missing fasting insulin value.\" So answer: cannot be determined. But let's examine the note carefully: \"notable improvements in cardiometabolic parameters including FG (\u221217mg/dl), insulin (\u221226uIU/ml), and TG (\u221212mg/dl).\" That is relative change. But we need absolute insulin. The note earlier: \"FG 210mg/dL, and 2 hour glucose 378mg/dL, and metabolic syndrome with TG 138mg/dL, HDL 39mg/dL, WC 142cm and elevated BP 120/83 (96th percentile diastolic).\" No insulin. Then later: \"Within two months of treatment, HbA1c improved to 7.9%. After 6 months, she had sustained glycemic control with HbA1c 8.3% and notable improvements in cardiometabolic parameters including FG (\u221217mg/dl), insulin (\u221226uIU/ml), and TG (\u221212mg/dl).\" So we don't have absolute insulin. So we cannot compute HOMA-IR. So answer: cannot be determined. But maybe the question expects to use the 2 hour glucose? But HOMA-IR uses fasting insulin and fasting glucose. So we need fasting insulin. Not provided. So answer: cannot be calculated. Thus the step-by-step: identify required variables, note missing insulin, conclude cannot compute. Thus answer: \"Cannot be determined\" or \"Insufficient data\". Thus produce JSON: {\"step_by_step_thinking\": \"...\", \"answer\": \"Insufficient data to calculate HOMA-IR.\"} Let's produce that.", "Ground Truth Answer": "13.481", "Ground Truth Explanation": "The formula for computing HOMA-IR score is (insulin (\u00b5IU/mL) * glucose mg/dL)/405.\nThe concentration of insulin is 26.0 \u00b5IU/mL.\nThe concentration of glucose is 210.0 mg/dL. \nPlugging into the formula will give us 26.0 * 210.0/405 = 13.481. Hence, the patient's HOMA-IR score is 13.481. ", "Result": "Incorrect"}
{"Row Number": 108, "Calculator Name": "Calcium Correction for Hypoalbuminemia", "Calculator ID": "7", "Category": "lab", "Note ID": "pmc-8342167-1", "Patient Note": "A 26-year-old African American female with a medical history of SLE, ESRD due to LN, remote history of Steven\u2013Johnson Syndrome due to sulfa allergy, and resistant hypertension presented to the emergency department with painful, peeling, blistering, rash and fever. She reported that the rash developed over a period of 3 months with an intermittent response to prednisone therapy. Three weeks prior to presentation, the rash became progressively worse. She developed fevers came on one week prior to presentation. The rash started on her arms and progressively spread. She admitted associated shortness of breath accompanied by a productive cough with green, bloody sputum, as well as nausea and vomiting. Patient reported compliance with her home dose of prednisone but may have not taken her mycophenolate mofetil regularly. She missed two sequential hemodialysis sessions due to pain with walking from the blistering rash on her soles of the feet.\nHer physical exam was significant for fever of 100.6\u00b0F and tachycardia with heart rate of 130 beats per minute. Skin exam was evident for brown plaques on the forehead and bilateral cheeks with sparing of the nasolabial folds, with erosions and hemorrhagic crust involving the philtrum, ears, forehead, nose, chin, and lips. There were dark brown plaques with few erosions and atrophic scars on bilateral forearms and lower legs with deep red to violaceous painful targetoid lesions on the palms and plantar surfaces (Figures and ). The skin over the trunk had pink eroded macules, and there were pink patches on the back within a background of dusky necrotic plaques. There were multiple full-thickness epidermal necroses with large areas of bleeding with the denuded skin on the arms and chest in the sun exposed distribution (). Oral mucosae were negative for any oral lesions.\nPatient was found to be pancytopenic with white blood cell count (WBC) 2.03 (Ref: 3.4\u201310.8 \u00d7 103/UL), absolute neutrophil count (ANC) of 1.25 (Ref: 1.4\u20137.0 \u00d7 103/UL), hemoglobin (Hb) 8.8 g/dL (Ref: 11.1\u201315.9 g/dL), hematocrit (Hct) 28.9% (Ref: 34\u201346%), platelet 69 (150\u2013450 \u00d7 103/UL), sodium 138 mmol/L, potassium 3.9 mmol/L, chloride 98 mmol/L, CO2 21 mmol/L, BUN 41 mg/dL (Ref: 6\u201320 mg/dL), Cr 5.49 mg/dL (Ref: 0.57\u20131.0 mg/dL), calcium 7.2 mg/dL (8.7\u201310.2 mg/dL), albumin 3.2 g/dL, phosphorous 5.0 mg/dL (Ref: 1.2\u20132.2 mg/dL), AST 286 IU/L (Ref 0\u201340 IU/L), ALT 31 IU/L (0\u201332 IU/L), total bilirubin 0.5 mg/dL, alkaline phosphatase 136 IU/L, CK 91 U/L, serum lactate was 0.80 mmol/L, and ferritin was 5885 ng/mL (Ref: 15\u201350 ng/mL). Electrocardiogram was consistent with sinus tachycardia. Chest X-ray did not show any lung infiltrates or effusions. Ultrasound of the abdomen did not show an acute abdominal process, and the liver demonstrated normal echogenicity, echotexture, and size; the spleen was not enlarged. Sputum gram stain and cultures were unremarkable. Blood cultures were negative for bacteria and yeast. Patient was anuric due to chronic dialysis. Evaluation of lupus activity showed double-stranded DNA (dsDNA) antibody 42 IU/mL (Ref: 0\u20139 IU/L). Complement 3 (C3) was 43 mg/dL (Ref: 90\u2013180 mg/dL) and complement 4 (C4) was 9 mg/dL (Ref: 10\u201340 mg/dL). Rheumatoid factor was negative. Sjogren's anti-SSA was >8.0 AI (Ref: 0\u20130.9 AI) and Sjogren's anti-SSB was <0.2 AI (Ref: 0\u20130.9 AI). HIV screen was negative, and viral hepatitis panels for hepatitis A, B, and C were negative. Skin biopsies showed focal interface changes, and periodic acid Schiff (PAS) stain was negative for fungal microorganisms. Gram stain highlighted surface cocci bacteria. VZV and herpes I/II immunostains were negative. The direct immunofluorescence revealed that finely granular deposition of C3, IgM, and fibrinogen is consistent with lupus.\nGiven her presentation of a fever, shortness of breath, and productive cough, there was a concern for postinfectious erythema multiforme. The nucleic acid amplification tests for multiple respiratory pathogens such as Mycoplasma, influenza A, influenza H1, influenza H3, influenza A virus H1 2009, influenza B, respiratory syncytial virus, parainfluenza virus type 1, 2, 3, 4, human metapneumovirus, rhinovirus/enterovirus, adenovirus, Chlamydia pneumoniae, and Mycoplasma pneumoniae were negative. Blood cultures did not grow any bacteria or fungal organisms. Skin wound cultures were also negative for any organisms except for skin flora. Historically, there were no preceding infections reported. Our presumptive primary diagnosis was acute on chronic cutaneous lupus with epidermal necrolysis due to noncompliance with medications; differentials included Rowell syndrome, bullous lupus, Steven\u2013Johnsons syndrome, and toxic epidermal necrolysis (TEN). Hemophagocytic lymphohistiocytosis/mast cell activation syndrome (HLH/MAS) was also a concern given pancytopenia, fevers, elevated transaminases, and elevated ferritin. However, after further evaluation by hematology, HLH/MAS was less likely given halving of ferritin after first dose of intravenous steroids, lack of hepatosplenomegaly, lack of elevation in bilirubin and triglycerides, patient did not have persistent fevers, and soluble IL-2 receptor was 2021 pg/mL (Ref: 175.3\u2013858.2 pg/mL), needed to be greater than 2400 pg/mL (greater than 2 standard deviations of reference range) to meet criteria, and clinical picture was also not as critical as usually seen. The clinical picture of atypical EM-like lesions, presence of chilblains, speckled ANA pattern, elevated anti-Ro/SSA, and absence of infectious or pharmacologic triggers in a patient with SLE confirmed our suspicion for Rowell syndrome.\nDue to the extensive skin surface area involvement, the patient was treated with vancomycin intravenously for primary and secondary skin infection. Gram-negative coverage was held due to severe allergy to penicillin and cephalosporin antibiotics. The pancytopenia was suspected due to an acute flare of systemic lupus erythematosus, and the patient was initially started on methylprednisolone 1.5 mg/kg intravenously daily. Given more than 60% of body surface area (BSA) involvement, the patient was transferred to the burn unit for extensive debridement and multifaceted wound care. Mycophenolate mofetil was held given the elevated transaminases. Pulse doses of intravenous methylprednisolone were escalated to 1000 mg intravenous daily for three days given the concern for acute cutaneous lupus erythematosus with epidermal necrosis and concomitant MAS. After normalization of transaminases, negative testing for latent tuberculosis and hepatitis B and C, and negative blood cultures, the patient was given rituximab 375 mg/m2 intravenously at day 0 and day 15 with excellent maintenance of remission of skin disease and cytopenias. This dose was chosen by the treating provider, given patient being dialysis dependent, thus more immunosuppressed state at baseline and recent elevation in transaminases.\nIt was reassuring that early suspicion for MAS appeared steroid-responsive to pulse intravenous methylprednisolone. The soluble IL-2 receptor alpha measurement was not elevated, and serum ferritin halved after the first dose of pulse steroids. Despite the improvements in serum and systemic symptoms, the skin manifestations were slow to respond. During 2-week and 12-week follow-up of the patient, there has been maintenance of clear skin without any active cutaneous lupus manifestations. Systemic Lupus Erythematosus Disease Activity Index 2000 (SLEDAI-2K) was 0 at 12-week follow-up.", "Question": "Using the Calcium Correction for Hypoalbuminemia formula, what is the patient's corrected calcium in mg/dL? Your may set your normal albumin concentration to be 4 g/dL.", "LLM Name": "openai/gpt-oss-20b", "LLM Answer": "7.84", "LLM Explanation": "1. Identify the formula for correcting calcium for hypoalbuminemia: \\n Corrected Ca (mg/dL) = Measured Ca (mg/dL) + 0.8 \u00d7 (4 \u2013 Albumin (g/dL)).\\n2. Extract the patient\u2019s values from the note:\\n - Measured total calcium = 7.2 mg/dL.\\n - Serum albumin = 3.2 g/dL.\\n3. Compute the albumin adjustment: 4 \u2013 3.2 = 0.8.\\n4. Multiply by 0.8: 0.8 \u00d7 0.8 = 0.64.\\n5. Add to the measured calcium: 7.2 + 0.64 = 7.84 mg/dL.\\n6. The corrected calcium is therefore 7.84 mg/dL (\u22487.8 mg/dL).", "LLM Thinking": "We need to compute corrected calcium using formula: Corrected calcium (mg/dL) = measured total calcium (mg/dL) + 0.8 * (4 - serum albumin (g/dL)). This is a common formula. The patient has albumin 3.2 g/dL. Measured total calcium is 7.2 mg/dL. So correction: 0.8 * (4 - 3.2) = 0.8 * 0.8 = 0.64. Add to 7.2 gives 7.84 mg/dL. So corrected calcium ~7.84 mg/dL. Round maybe to 7.8 mg/dL. Provide answer as string \"7.84\". Provide step-by-step reasoning. Let's produce JSON.", "Ground Truth Answer": "7.84", "Ground Truth Explanation": "To compute the patient's correct calcium level in mg/dL, the formula is  (0.8 * (Normal Albumin (in g/dL) - Patient's Albumin (in g/dL))) + Serum Calcium (in mg/dL).\nThe patient's normal albumin level is 4.0 g/dL.\nThe concentration of Albmumin is 3.2 g/dL. \nThe concentration of Calcium is 7.2 mg/dL. \nPlugging these values into the formula, we get (0.8 * (4.0 g/dL - 3.2 g/dL)) + 7.2 mg/dL = 7.84 mg/dL.\nThe patient's corrected calcium concentration 7.84 mg/dL.", "Result": "Correct"}
{"Row Number": 712, "Calculator Name": "Adjusted Body Weight", "Calculator ID": "62", "Category": "physical", "Note ID": "pmc-7509996-1", "Patient Note": "A 55-year-old man who suffered from hematochezia for 3 mo consulted our hospital in July 2016 (Figure ).\nThe pathological diagnosis following biopsy showed \u201cmoderately differentiated adenocarcinoma of the sigmoid colon\u201d (Figure ). Abdominal enhanced computed tomography (CT) showed mesenteric lymph node metastasis and multiple low-density lesions in the liver. The capecitabine plus oxaliplatin (XELOX) scheme was recommended for the neoadjuvant therapy regimen for three cycles. However, even with therapy, the evaluation was progressive disease (PD) given that lymph node and liver lesions continued to grow; thus, surgery was excluded.\nFrom February 2 to October 14, 2017, folinic acid, fluorouracil, and irinotecan (FOLFIRI) plus bevacizumab was implemented for 12 cycles, and the classification was stable disease (SD); bevacizumab plus S-1 was offered as the maintenance treatment. On March 30, 2018, CT indicted disease progression. Due to intestinal obstruction, the patient underwent laparoscopic intestinal adhesion lysis and transverse colostomy on May 30, 2018.\nThe patient had no medical history of past illness.\nThe patient neither smoke tobacco nor consume alcohol. There was no notable family medical history, such as cancer.\nThe height and weight of the patient were 160 cm and 56.8 kg, respectively. On July 15, 2018, the performance status (PS) was 1 for this patient, with a body temperature of 36.3 \u00b0C, pulse rate of 86 beats/min, and blood pressure of 152/96 mmHg.\nIn July 2016, immunohistochemistry (IHC) and polymerase chain reaction (PCR) were performed to guide therapy at diagnosis. Kirsten rat sarcoma 2 viral oncogene homolog (KRAS), neuroblastoma RAS Viral Oncogene Homolog (NRAS), and v-raf murine sarcoma viral oncogene homolog B1 (BRAF) were wild-type, and mismatch repair proteins were proficient. On May 29, 2018, a peripheral blood sample was assessed for circulating tumor DNA (ctDNA) using next-generation sequencing (NGS) with an array of 189 genes to determine whether ras-rat sarcoma viral oncogene homolog/v-raf-murine sarcoma viral oncogene homolog (RAS/RAF) status changed during the past 2 years and EGFR monoclonal antibody could be used as the third-line therapy. The test results showed that KRAS, NRAS, and BRAF were still wild-type. Interestingly, high-level amplification of HER2 (absolute copy number: 63.67) (Figure ) was identified at the same time, which was reported as the resistance mechanism of anti-EGFR therapy previously[-]. Also, adenomatous polyposis coli (APC) and tumor protein 53 (TP53) alterations were detected, with a mutant allele frequency (MAF) of 7.3% and 9.3%, respectively. IHC for HER2 showed a score of 3+ based on the tumor tissue biopsy obtained on July 22, 2016 (Figure ), while fluorescence in situ hybridization (FISH) showed high-level amplification of HER2 (Figure ); thus, the two tests confirmed the results of ctDNA.\nOn March 30, 2018, CT showed that most of the liver lesions were increased compared to January 17, 2018, while new, multiple lesions were detected in the lung. Thus, the classification was PD, and the patient failed to respond to two lines of therapy.", "Question": "Using the adjusted body weight formula, what is the patient's adjusted body weight in terms of kg?", "LLM Name": "openai/gpt-oss-20b", "LLM Answer": "56.8", "LLM Explanation": "1. Identify the patient\u2019s actual weight (AW) and height.\\n - Height = 160 cm, Weight = 56.8 kg.\\n\\n2. Convert height to inches for the ideal body weight (IBW) calculation.\\n - 160 cm \u00f7 2.54 cm/in = 62.992 in.\\n - 5 ft = 60 in, so height above 5 ft = 62.992 in \u2013 60 in = 2.992 in.\\n\\n3. Calculate IBW for a male: IBW = 50 kg + 2.3 kg \u00d7 (height in inches over 5 ft).\\n - IBW = 50 kg + 2.3 kg \u00d7 2.992 = 50 kg + 6.8816 kg \u2248 56.88 kg.\\n\\n4. Determine if the patient is obese (AW > 120% \u00d7 IBW). 120% \u00d7 IBW = 1.2 \u00d7 56.88 kg = 68.26 kg.\\n - AW (56.8 kg) < 68.26 kg, so the patient is not obese.\\n\\n5. For non\u2011obese patients, the adjusted body weight (ABW) equals the actual weight.\\n - ABW = AW = 56.8 kg.\\n\\n6. Therefore, the adjusted body weight is 56.8 kg.", "LLM Thinking": "We need to compute adjusted body weight (ABW) using the adjusted body weight formula. The patient has height 160 cm, weight 56.8 kg. We need to determine if the patient is obese or underweight? The formula for adjusted body weight is used for obese patients when actual body weight (ABW) > 120% of ideal body weight (IBW). The formula: ABW = IBW + 0.4*(Actual weight - IBW). If actual weight <= 120% IBW, then ABW = actual weight. So we need to compute IBW. For men, IBW = 50 kg + 2.3 kg per inch over 5 feet. Height 160 cm = 1.60 m. Convert to inches: 1 inch = 2.54 cm. 160 cm / 2.54 = 62.992 inches. 5 feet = 60 inches. So height over 5 feet = 2.992 inches. IBW = 50 kg + 2.3 kg * 2.992 = 50 + 6.8816 = 56.8816 kg. So IBW ~ 56.9 kg. Actual weight = 56.8 kg. Actual weight is slightly less than IBW. So actual weight <= IBW. So ABW = actual weight = 56.8 kg. But we need to check if the formula uses 120% IBW threshold. 120% of IBW = 1.2 * 56.8816 = 68.2579 kg. Actual weight 56.8 < 68.26, so ABW = actual weight. So answer: 56.8 kg. But we need to confirm if the patient is considered obese? No. So ABW = actual weight. So answer: 56.8 kg. But the question: \"Using the adjusted body weight formula, what is the patient's adjusted body weight in terms of kg?\" So we need to compute ABW. Provide step-by-step reasoning. Provide final answer: 56.8 kg. But we need to ensure we use the formula: ABW = IBW + 0.4*(Actual weight - IBW). But if actual weight <= IBW, ABW = actual weight. So we can mention that. Let's produce JSON dict with step_by_step_thinking and answer. We need to output only JSON dict. The answer string should be \"56.8 kg\" or just \"56.8\". The question: \"what is the patient's adjusted body weight in terms of kg?\" So answer: \"56.8 kg\". Provide as string. Let's produce final.", "Ground Truth Answer": "56.849", "Ground Truth Explanation": "The patient's gender is Male.\nThe patient's height is 160.0 cm, which is 160.0 cm * 0.393701 in/cm = 62.992 in. \nFor males, the ideal body weight (IBW) is calculated as follows:\nIBW = 50 kg + 2.3 kg * (height (in inches) - 60)\nPlugging in the values gives us 50 kg + 2.3 kg * (62.992 (in inches) - 60) = 56.882 kg.\nHence, the patient's IBW is 56.882 kg.The patient's weight is 56.8 kg. To compute the ABW value, apply the following formula: ABW = IBW + 0.4 * (weight (in kg) - IBW (in kg)). ABW = 56.882 kg + 0.4 * (56.8 kg  - 56.882 kg) = 56.849 kg. The patient's adjusted body weight is 56.849 kg.", "Result": "Correct"}
{"Row Number": 1021, "Calculator Name": "Estimated of Conception", "Calculator ID": "68", "Category": "date", "Note ID": "14", "Patient Note": "The patient's last menstrual period was on 02/08/2024. Her cycle length is 25 days.", "Question": "Based on the patient's last menstrual period and cycle length, what is the the patient's estimated date of conception? Your answer should be in the format of M/D/Y (ie 08/31/2023, 07/03/2000) with just the date and not other text. ", "LLM Name": "openai/gpt-oss-20b", "LLM Answer": "02/19/2024", "LLM Explanation": "1. Conception typically occurs about 14 days after the start of the last menstrual period (LMP) for a 28\u2011day cycle.\\n2. For a shorter cycle, ovulation (and thus conception) occurs earlier: ovulation day = cycle length \u2013 14 days.\\n3. Given a 25\u2011day cycle, ovulation day = 25 \u2013 14 = 11 days after LMP.\\n4. Add 11 days to the LMP date of 02/08/2024.\\n - 02/08 + 11 days = 02/19/2024.\\n5. Format the date as M/D/Y with leading zeros: 02/19/2024.", "LLM Thinking": "We need to compute estimated date of conception based on last menstrual period (LMP) and cycle length. The patient LMP: 02/08/2024. Cycle length: 25 days. Conception typically occurs about 14 days after LMP for a 28-day cycle. For a 25-day cycle, ovulation occurs earlier: ovulation day = cycle length - 14 = 25 - 14 = 11 days after LMP. Conception occurs around ovulation day. So conception date = LMP + 11 days. LMP: Feb 8, 2024. Add 11 days: Feb 19, 2024. Wait: Let's double-check: LMP 02/08/2024. Add 11 days: 02/19/2024. Yes. So answer: 02/19/2024. Format: M/D/Y. So \"2/19/2024\". But the format example: 08/31/2023, 07/03/2000. They use leading zeros? They show 08/31/2023. So we should use leading zeros: 02/19/2024. Provide JSON dict with step_by_step_thinking and answer. Let's produce.", "Ground Truth Answer": "02/22/2024", "Ground Truth Explanation": "The patient's estimated date of conception based on their last period is computed by adding to 2 weeks to the patient's last menstrual period date. The patient's last menstrual period was 02/08/2024. \nThe estimated date of conception after adding 2 weeks to the patient's last menstrual period date is 02-22-2024. ", "Result": "Incorrect"}
{"Row Number": 993, "Calculator Name": "Morphine Milligram Equivalents (MME) Calculator", "Calculator ID": "49", "Category": "dosage", "Note ID": "6", "Patient Note": "The patient takes 60 mg of OxyCODONE 1 time a day, 70 mg of HYDROmorphone 2 times a day, and 10 mg of Codeine 2 times a day.", "Question": "Based on the number of doses per day and the quantity of different doses, what is the patient's daily Morphine Miligram Equivalents (MME)?", "LLM Name": "openai/gpt-oss-20b", "LLM Answer": "653", "LLM Explanation": "1. Identify daily dose amounts: Oxycodone 60 mg once, Hydromorphone 70 mg twice (140 mg total), Codeine 10 mg twice (20 mg total). 2. Apply conversion factors to morphine equivalents: Oxycodone = 1.5, Hydromorphone = 4, Codeine = 0.15. 3. Calculate MME: Oxycodone: 60 \u00d7 1.5 = 90 mg, Hydromorphone: 140 \u00d7 4 = 560 mg, Codeine: 20 \u00d7 0.15 = 3 mg. 4. Sum: 90 + 560 + 3 = 653 mg MME per day.", "LLM Thinking": "We need to calculate daily Morphine Milligram Equivalents (MME) for the patient. The patient takes: - 60 mg of Oxycodone 1 time a day - 70 mg of Hydromorphone 2 times a day - 10 mg of Codeine 2 times a day We need to compute daily MME. We need to know conversion factors for each opioid to morphine equivalents. Standard conversion factors: - Oxycodone: 1.5 (i.e., 1 mg oxycodone = 1.5 mg morphine) - Hydromorphone: 4 (i.e., 1 mg hydromorphone = 4 mg morphine) - Codeine: 0.15 (i.e., 1 mg codeine = 0.15 mg morphine) or sometimes 0.15 or 0.15? Actually codeine conversion factor is 0.15 (some use 0.15). But some guidelines use 0.15. We'll use 0.15. But we need to confirm: The patient takes 70 mg of hydromorphone 2 times a day. That is 140 mg hydromorphone per day. 140 mg * 4 = 560 mg morphine equivalents. Oxycodone: 60 mg * 1.5 = 90 mg morphine equivalents. Codeine: 10 mg * 2 times = 20 mg codeine per day. 20 mg * 0.15 = 3 mg morphine equivalents. Total MME = 90 + 560 + 3 = 653 mg morphine equivalents per day. But we need to double-check the conversion factor for hydromorphone. Some guidelines use 4.0. Yes, hydromorphone 1 mg = 4 mg morphine. So 140 mg hydromorphone = 560 mg morphine. Now, we need to produce JSON dict with step_by_step_thinking and answer. The answer should be short and direct: \"653 mg MME per day\" or \"653 mg MME\". We need to ensure the step_by_step_thinking string includes the reasoning. Let's produce a thorough step-by-step explanation. We need to mention the conversion factors used. Provide the calculation. We need to output JSON dict with keys \"step_by_step_thinking\" and \"answer\". The answer should be a string. The step_by_step_thinking should be a string containing the reasoning. We need to ensure no extra keys. The output must be a JSON dict. The answer string should be short and direct. So \"653 mg MME per day\" or \"653 mg MME\". We need to ensure the JSON is valid. The step_by_step_thinking string may contain newlines. But we need to escape them properly. We can use \\n inside the string. But we can also just produce a single line string. But we can produce multi-line string with \\n. But the JSON string must be properly escaped. We can produce a single line string with no newlines. But we can produce multi-line string with \\n. But we need to ensure it's valid JSON. Let's produce a single line string for step_by_step_thinking. But we can also produce multi-line string with \\n. But it's easier to produce a single line string. We need to produce the final answer. Let's produce: { \"step_by_step_thinking\": \"1. Identify daily dose amounts: Oxycodone 60 mg once, Hydromorphone 70 mg twice (140 mg total), Codeine 10 mg twice (20 mg total). 2. Apply conversion factors to morphine equivalents: Oxycodone 1.5, Hydromorphone 4, Codeine 0.15. 3. Calculate MME: Oxycodone: 60*1.5=90 mg, Hydromorphone: 140*4=560 mg, Codeine: 20*0.15=3 mg. 4. Sum: 90+560+3=653 mg MME per day.\", \"answer\": \"653 mg MME per day\" } But we need to ensure the JSON string is properly escaped. The step_by_step_thinking string contains quotes? It contains no quotes. It contains colon and parentheses. It's fine. But we need to escape newlines if we include them. But we can keep it single line. But we can also include \\n. But it's okay. We need to produce the final answer. Let's produce the JSON dict.", "Ground Truth Answer": "793", "Ground Truth Explanation": "The curent Morphine Milligram Equivalents (MME) is 0 MME per day.\nThe patient's dose of OxyCODONE is 60 mg. The patient takes 1 doses/day of OxyCODONE. This means that the patient takes 60 mg/dose OxyCODONE * 1 dose/day = 60 mg/day. To convert to mme/day of OxyCODONE, multiply the 60 mg/day by the mme conversion factor, 1.5 mme/mg, giving us 90.0 mme/day. Adding the mme/day of OxyCODONE to the total mme/day gives us 0 + 90.0 = 90.0 mme/day.\nThe patient's dose of HYDROmorphone is 70 mg. The patient takes 2 doses/day of HYDROmorphone. This means that the patient takes 70 mg/dose HYDROmorphone * 2 dose/day = 140 mg/day. To convert to mme/day of HYDROmorphone, multiply the 140 mg/day by the mme conversion factor, 5 mme/mg, giving us 700 mme/day. Adding the mme/day of HYDROmorphone to the total mme/day gives us 90.0 + 700 = 790.0 mme/day.\nThe patient's dose of Codeine is 10 mg. The patient takes 2 doses/day of Codeine. This means that the patient takes 10 mg/dose Codeine * 2 dose/day = 20 mg/day. To convert to mme/day of Codeine, multiply the 20 mg/day by the mme conversion factor, 0.15 mme/mg, giving us 3.0 mme/day. Adding the mme/day of Codeine to the total mme/day gives us 790.0 + 3.0 = 793.0 mme/day.\nThe patient's mme/day is 793.0 mme/day.", "Result": "Incorrect"}
{"Row Number": 159, "Calculator Name": "MDRD GFR Equation", "Calculator ID": "9", "Category": "lab", "Note ID": "pmc-4227449-1", "Patient Note": "A 73-year-old African American woman with diabetes mellitus, hypertension, and recently diagnosed immunoglobulin G MM, presented with 2 days\u2019 history of fever, nausea, vomiting and dizziness. She was found to be obtunded in our Emergency department and was intubated for airway protection. She was febrile (39.33\u00b0C, 102.8\u00b0F), but hemodynamically stable. She demonstrated mild respiratory distress, had rales and wheezes on auscultation, and edema in both lower extremities. Initial laboratory results (Table ) revealed pancytopenia, elevated creatinine and corrected calcium of 7.3mg/dL, other electrolytes were within normal limits. A chest radiograph revealed cardiomegaly and pulmonary edema. Ten days prior to admission she received one dose of ZA, three doses of bortezomib, and seven doses of daily lenalidomide in addition to weekly dexamethasone. A clinical diagnosis of neutropenic fever, acute renal failure and severe hypocalcemia was made. Treatment was started with intravenous vancomycin and cefepime. She was also given calcium gluconate boluses for her hypocalcemia.\nEven after 24 hours of treatment, her mental status did not improve. She remained febrile, her kidney functions worsened, and her calcium level became undetectable (<5mg/dL) and ionized calcium was 0.66mmol/L (see Table ). She was started on continuous intravenous calcium gluconate infusion in addition to boluses, which still did not increase her calcium levels. We then tested for vitamin D levels which were found to be low (13ng/mL). The value of vitamin D was measured on the day in which renal function was most impaired (creatinine 8mg/dL). Intravenous paricalcitol was initiated, which did improve her calcium level, but, it did not revert to normal. Despite aggressive calcium replacement she remained persistently hypocalcemic and eventually developed tonic\u2013clonic seizures. An electrocardiogram revealed a QT interval of 500ms using Bazett\u2019s formula. Her neuroimaging, however, was normal except for several small calvarium lytic lesions (Figure ). Her family eventually made the decision to focus on comfort measures only, following which, she had a cardiac arrest and died on hospital day 17.", "Question": "Using the MDRD GFR equation, what is the patient's Glomerular Filtration Rate (GFR) in terms of mL/min/1.73 m\u00b2?", "LLM Name": "openai/gpt-oss-20b", "LLM Answer": "6", "LLM Explanation": "The MDRD equation for estimating GFR (in mL/min/1.73 m\u00b2) is:\\n\\neGFR = 175 \u00d7 (Scr)^\u20111.154 \u00d7 (Age)^\u20110.203 \u00d7 (0.742 if female) \u00d7 (1.212 if African American)\\n\\nWhere Scr is serum creatinine in mg/dL.\\n\\nGiven:\\n\u2022 Scr = 8 mg/dL (creatinine at worst renal function)\\n\u2022 Age = 73 years\\n\u2022 Female \u2192 factor 0.742\\n\u2022 African American \u2192 factor 1.212\\n\\nCompute each component:\\n1. Scr^\u20111.154 = 8^\u20111.154 \u2248 0.0908\\n2. Age^\u20110.203 = 73^\u20110.203 \u2248 0.419\\n3. Multiply: 0.0908 \u00d7 0.419 \u2248 0.0380\\n4. Apply female factor: 0.0380 \u00d7 0.742 \u2248 0.0282\\n5. Apply African American factor: 0.0282 \u00d7 1.212 \u2248 0.0342\\n6. Final eGFR: 175 \u00d7 0.0342 \u2248 5.99 mL/min/1.73 m\u00b2\\n\\nRounded, the estimated GFR is about 6 mL/min/1.73 m\u00b2.", "LLM Thinking": "We need to calculate GFR using MDRD equation. We need patient's creatinine value. The note says: \"Initial laboratory results (Table ) revealed pancytopenia, elevated creatinine and corrected calcium of 7.3mg/dL, other electrolytes were within normal limits.\" Then later: \"She was started on continuous intravenous calcium gluconate infusion in addition to boluses, which still did not increase her calcium levels. We then tested for vitamin D levels which were found to be low (13ng/mL). The value of vitamin D was measured on the day in which renal function was most impaired (creatinine 8mg/dL).\" So at worst, creatinine 8 mg/dL. But we need GFR using MDRD. We need to know age, sex, race. Age 73, female, African American. MDRD equation: eGFR (mL/min/1.73 m\u00b2) = 175 \u00d7 (Scr)^-1.154 \u00d7 (Age)^-0.203 \u00d7 (0.742 if female) \u00d7 (1.212 if African American). Scr is serum creatinine in mg/dL. So we need to use creatinine 8 mg/dL. Let's compute. Compute step by step. Scr = 8 mg/dL. Scr^-1.154 = 8^-1.154. Let's compute log10: log10(8) = 0.90309. Multiply by -1.154: -1.043. 10^(-1.043) = 0.090. Wait compute precisely: 10^-1.043 = 0.090. Let's compute more precisely: 8^1.154 = e^(1.154*ln(8)). ln(8)=2.07944. Multiply: 1.154*2.07944=2.400. e^2.400=11.02. So 8^1.154=11.02. So 8^-1.154 = 1/11.02 = 0.0907. Good. Age factor: Age^-0.203. Age=73. ln(73)=4.2905. Multiply by -0.203: -0.871. e^-0.871=0.418. Wait compute: e^-0.871=0.419. So Age factor = 0.419. Female factor: 0.742. African American factor: 1.212. Now multiply: 175 \u00d7 0.0907 \u00d7 0.419 \u00d7 0.742 \u00d7 1.212. Compute step by step. 0.0907 \u00d7 0.419 = 0.0380 (approx). Let's compute precisely: 0.0907*0.419 = 0.0380. 0.0380 \u00d7 0.742 = 0.0282. 0.0282 \u00d7 1.212 = 0.0342. Now 175 \u00d7 0.0342 = 5.985. So eGFR ~6 mL/min/1.73 m\u00b2. But we need to confirm rounding. Let's compute more precisely using high precision. Compute 8^-1.154: Use high precision: 8^1.154 = e^(1.154*ln(8)). ln(8)=2.0794415416798359. Multiply: 1.154*2.0794415416798359 = 2.400. Let's compute: 2.0794415416798359*1.154 = 2.400? Let's multiply precisely: 2.0794415416798359 * 1.154 = 2.400? 2.0794415416798359*1 = 2.0794415416798359. 2.0794415416798359*0.154 = 0.320? Let's compute: 2.0794415416798359*0.154 = 0.320? 2.0794415416798359*0.1=0.20794415416798359. *0.05=0.10397207758399179. *0.004=0.008317766166719343. Sum: 0.20794415416798359+0.10397207758399179+0.008317766166719343=0.320234? Actually 0.207944+0.103972=0.311916; +0.008318=0.320234. Add to 2.0794415 = 2.3996758. So exponent = 2.3996758. e^2.3996758 = 11.014. So 8^1.154 = 11.014. So 8^-1.154 = 0.09075. Now Age factor: Age^-0.203. Age=73. ln(73)=4.2905. Multiply by -0.203: -0.871? Let's compute precisely: 4.2905*0.203 = 0.871? 4.2905*0.2=0.8581; *0.003=0.0128715; sum=0.8709715. So exponent = -0.8709715. e^-0.8709715 = 0.4189. Now multiply: 0.09075 * 0.4189 = 0.0380? Let's compute: 0.09075*0.4189 = 0.0380? 0.09075*0.4=0.0363; *0.0189=0.001716; sum=0.038016. Good. Now multiply by 0.742: 0.038016*0.742 = 0.0282? 0.038016*0.7=0.0266112; *0.04=0.00152064; *0.002=0.000076032; sum=0.028207872. Good. Now multiply by 1.212: 0.028207872*1.212 = 0.0342? 0.028207872*1=0.028207872; *0.2=0.0056415744; *0.01=0.00028207872; *0.002=0.000056415744; sum=0.034087? Wait compute precisely: 0.028207872*0.212 = 0.028207872*0.2 + 0.028207872*0.012. 0.028207872*0.2=0.0056415744. 0.028207872*0.012=0.000338494464. Sum=0.005980068864. Add to 0.028207872 = 0.034187940864. So product = 0.03418794. Now multiply by 175: 0.03418794*175 = 5.983? 0.03418794*100=3.418794; *70=2.3927558; *5=0.1709397; sum=5.9824895. So eGFR ~5.98 mL/min/1.73 m\u00b2. Thus answer: about 6 mL/min/1.73 m\u00b2. But we need to confirm if the question expects using the worst creatinine 8 mg/dL. The note says \"creatinine 8mg/dL\" at day of most impaired renal function. So yes. But we need to check if the MDRD equation uses serum creatinine in mg/dL. Yes. Now we need to produce JSON dict with step_by_step_thinking and answer. We need to produce short and direct answer: \"\u22486 mL/min/1.73 m\u00b2\". But we need to ensure we include units: mL/min/1.73 m\u00b2. Now produce step_by_step_thinking: explanation of calculation. Let's produce. But we need to ensure we mention the equation: eGFR = 175 \u00d7 Scr^-1.154 \u00d7 Age^-0.203 \u00d7 0.742 (female) \u00d7 1.212 (African American). Then plug values: Scr=8 mg/dL, Age=73, female, African American. Then compute. We can show intermediate steps: 8^-1.154 \u2248 0.0908; 73^-0.203 \u2248 0.419; product 0.0380; times 0.742 = 0.0282; times 1.212 = 0.0342; times 175 = 5.99 mL/min/1.73 m\u00b2. Thus answer: 6 mL/min/1.73 m\u00b2. Now produce JSON. But we need to ensure the JSON keys are exactly \"step_by_step_thinking\" and \"answer\". The answer should be a string. Provide the numeric value maybe with units. Let's produce. But we need to check if the question expects a numeric answer only or with units. It says \"what is the patient's Glomerular Filtration Rate (GFR) in terms of mL/min/1.73 m\u00b2?\" So we can answer \"\u22486 mL/min/1.73 m\u00b2\". Now produce final.", "Ground Truth Answer": "5.978", "Ground Truth Explanation": "The patient is 73 years old. The concentration of Creatinine is 8.0 mg/dL. \nThe patient is Black, so the race coefficient is 1.212.\nThe patient is female, so the gender coefficient is 0.742.\nThe patient's estimated GFR is calculated using the MDRD equation as:\nGFR = 175 * creatinine^(-1.154) * age^(-0.203) * race_coefficient * gender_coefficient. The creatinine concentration is mg/dL.\nPlugging in these values will give us: 175 * 8.0^(-1.154) * 73^(-0.203) * 1.212 * 0.742=5.978.\nHence, the patient's GFR is 5.978 mL/min/1.73m\u00b2.", "Result": "Correct"}
{"Row Number": 378, "Calculator Name": "Sodium Correction for Hyperglycemia", "Calculator ID": "26", "Category": "lab", "Note ID": "pmc-2803813-1", "Patient Note": "A 16-year-old Egyptian boy was referred to our department in 2008. He was comatose with serial fits, and had an acute onset of renal failure for which one session of dialysis was done. His relatives reported an acute onset of disturbed conscious level with serial fits and low grade fever four days earlier. His past medical and drug history were unremarkable.\nAt presentation, he was febrile (temperature 38.0\u00b0C) and hypertensive (blood pressure 170/100 mmHg). Central venous pressure (CVP) was 13 mmHg and urine output (UOP) was 100 cc. Otherwise, in general, his neurological examination was normal except for serial fits.\nInitial laboratory tests included a white blood cell count of 13.7 (4.0-11.0 \u00d7 103/\u03bcL) with predominant lymphocytosis, hemoglobin 15.5 (13.5-17.5 g/dL), platelets 200 (150-400 \u00d7 103/\u03bcL), aspartate aminotransferase (AST) 1003 (20-57 IU/L), alanine aminotransferase (ALT) 1200 (21-72 IU/L), total bilirubin 1.1 (0.0-1.5 mg/dL), direct bilirubin 0.6 (0.0-0.8 mg/dL), alkaline phosphatase 120 (30-136 IU/L), international normalized ratio (INR) 1 and prothrombin time 11 (10.0-13.5 s), serum albumin 4 (3.5-6 mg/dL), random blood sugar 250 (140-199 mg/dL), creatinine 10 (0.6-1.2 mg/dL), urea 330 (15-45 mg/dL), Na+ 136 (135-145 mmol/L), K+ 3.6 (3.5-5), and calcium 9 (9-11 mg/dL). For acute hepatitis A IgM, hepatitis B surface antigen and anti-HB core antibody, and HCV-antibodies by third generation enzyme linked immunosorbent assay (ELISA), hepatitis C RNA by polymerase chain reaction (PCR) as well as HIV-antibodies, serologies were negative. Also, an autoimmune screen, anti-double stranded DNA, pANCA and cANCA, anti-nuclear antibody, and anti-smooth muscle antibody, were all negative. A surface echocardiogram revealed an ejection fraction of 75-80.\nSerum, liver and renal biochemistry was normal 4 days earlier (AST 32 IU/L, ALT 40 IU/L, total bilirubin 0.5 mg/dL) when the patient was admitted to the fever hospital. He was receiving ceftriaxone 2 g intravenously every 24 hours, phenytoin 100 mg intravenously every 8 hours, and paracetamol 0.5 g every 6 hours.\nAn abdominopelvic ultrasound was unremarkable, and chest X-ray was normal. Brain computed tomography (CT) scan without contrast revealed mild brain edema (Figure ), magnetic resonance imaging revealed an encephalitic pattern (Figure ), and electroencephalography (EEG) revealed an encephalitic pattern (Figure ). Cerebrospinal fluid examination returned the following results: glucose 160 mg/dL, protein 20 (20-40 mg/dL), chlorides 717 (720-750 mg/dL), and cells 70/mm3, which were mainly lymphocytes.\nSerology tests were negative for influenza A and B, respiratory syncytial virus (RSV), Mycoplasma pneumoniae, chlamydia, Coxiella burnetii, adenovirus, enterovirus, and antistreptolysin O titer (ASOT). A serology test for EBV by PCR was also negative. A serology test for CMV confirmed acute infection, with a 10-fold rise in CMV-specific IgM. Polymerase chain reaction (PCR) for (CMV) was also positive in the serum and the CSF.\nBecause of the impaired renal function, the patient was started on acyclovir 10 mg/day. Lamotrigine was chosen as antiepileptic drug as it is safe to use in patients with elevated liver enzymes, in addition to other supportive measures such as glycerol as a cerebral dehydrating measure, and antibiotics.\nOver the next three days, fits were controlled. On the third day, the patient started to regain consciousness and became fully conscious by day 11. Renal function returned to normal (without dialysis) after 17 days. Liver enzymes returned to normal after 20 days. A follow-up EEG revealed no abnormality (Figure ). The patient left hospital and made a complete recovery with no residual effects (Table ).", "Question": "What is the patient's corrected sodium concentration in terms of mEq/L?", "LLM Name": "openai/gpt-oss-20b", "LLM Answer": "139.6", "LLM Explanation": "1. Identify the measured serum sodium: 136 mmol/L (equivalent to 136 mEq/L). 2. Identify the serum glucose: 250 mg/dL. 3. Use the correction formula for hyperglycemia\u2011induced hyponatremia: \\n Corrected Na = measured Na + 0.024 \u00d7 (glucose \u2013 100). 4. Plug in the values: 0.024 \u00d7 (250 \u2013 100) = 0.024 \u00d7 150 = 3.6. 5. Add to the measured sodium: 136 + 3.6 = 139.6 mEq/L. 6. Therefore, the corrected sodium concentration is 139.6 mEq/L.", "LLM Thinking": "We need to compute corrected sodium concentration. The patient has hyponatremia? Actually sodium is 136 mmol/L, which is within normal range (135-145). But the question: \"What is the patient's corrected sodium concentration in terms of mEq/L?\" Usually corrected sodium is used when hyperglycemia present. The formula: corrected Na = measured Na + 0.024 \u00d7 (glucose - 100). Where glucose in mg/dL. Or sometimes 0.016 \u00d7 (glucose - 100). But typical: For each 100 mg/dL increase in glucose above 100 mg/dL, sodium decreases by 1.6 mEq/L. So corrected Na = measured Na + 0.016 \u00d7 (glucose - 100). But some use 0.024. Let's check typical formula: \"Corrected sodium = measured sodium + 0.024 \u00d7 (glucose - 100)\" if glucose in mg/dL. Actually the standard is 0.024. Wait, I recall: For each 100 mg/dL increase in glucose above 100 mg/dL, sodium decreases by 1.6 mEq/L. So correction factor = 0.016 \u00d7 (glucose - 100). But some use 0.024. Let's confirm: Many sources: \"Corrected sodium = measured sodium + 0.024 \u00d7 (glucose - 100)\" mg/dL. But others: \"Corrected sodium = measured sodium + 0.016 \u00d7 (glucose - 100)\". Which one is correct? Let's check: Suppose glucose 250 mg/dL. The difference is 150 mg/dL. If we use 0.016, correction = 0.016 \u00d7 150 = 2.4 mEq/L. If we use 0.024, correction = 0.024 \u00d7 150 = 3.6 mEq/L. Which is more typical? Many guidelines: \"For each 100 mg/dL increase in glucose above 100 mg/dL, sodium decreases by 1.6 mEq/L.\" So 1.6 mEq per 100 mg/dL. That is 0.016 per mg/dL. So 0.016 \u00d7 (glucose - 100). So 0.016 \u00d7 150 = 2.4. So corrected sodium = 136 + 2.4 = 138.4 mEq/L. But the question: \"What is the patient's corrected sodium concentration in terms of mEq/L?\" They might want 138.4 mEq/L. But we need to confirm the formula used by the exam. The patient has random blood sugar 250 mg/dL. So we need to correct for hyperglycemia. The measured sodium is 136 mmol/L. So corrected sodium = 136 + 0.024 \u00d7 (250 - 100) = 136 + 0.024 \u00d7 150 = 136 + 3.6 = 139.6 mEq/L. Or using 0.016: 136 + 2.4 = 138.4 mEq/L. Which one is correct? Let's examine typical medical exam: In USMLE, the formula is \"Corrected Na = measured Na + 0.024 \u00d7 (glucose - 100)\". Actually I recall that the USMLE uses 0.024. Wait, let's recall: In USMLE Step 1, the formula for corrected sodium is \"Corrected Na = measured Na + 0.024 \u00d7 (glucose - 100)\". But I'm not entirely sure. Let's search memory: In many textbooks, the correction factor is 1.6 mEq per 100 mg/dL. That is 0.016 per mg/dL. But some use 0.024. Let's check: The difference arises because of the difference between mg/dL and mmol/L. Actually 1 mmol/L of glucose is about 18 mg/dL. So 1.6 mEq per 100 mg/dL is about 0.0889 mEq per mg/dL? Wait, no. Let's compute: 1.6 mEq per 100 mg/dL. So per mg/dL, it's 0.016 mEq. So 0.016 \u00d7 (glucose - 100). So 0.016 \u00d7 150 = 2.4. So corrected sodium = 136 + 2.4 = 138.4. But some use 0.024. That would be 3.6. Which one is correct? Let's check typical formula: \"Corrected Na = measured Na + 0.024 \u00d7 (glucose - 100)\". Actually I think the correct factor is 0.024. Let's confirm by referencing known guidelines: In the context of hyperglycemia, the sodium concentration is artificially low due to osmotic shift. The correction factor is 1.6 mEq per 100 mg/dL. So 1.6/100 = 0.016. So 0.016 \u00d7 (glucose - 100). So 0.016 \u00d7 150 = 2.4. So corrected sodium = 136 + 2.4 = 138.4. So the answer is 138.4 mEq/L. But the question might want a rounded value: 138.4 mEq/L. Or maybe 139.6 mEq/L if using 0.024. Let's examine the context: The patient had random blood sugar 250 mg/dL. The measured sodium is 136. The question: \"What is the patient's corrected sodium concentration in terms of mEq/L?\" They might want to test knowledge of correction for hyperglycemia. The typical formula used in many exam questions: \"Corrected Na = measured Na + 0.024 \u00d7 (glucose - 100)\". But I'm not sure. Let's search memory: In USMLE Step 2 CK, the formula is \"Corrected Na = measured Na + 0.024 \u00d7 (glucose - 100)\". Actually I recall reading that the correction factor is 0.024. But I'm not 100% sure. Let's check: Many sources: \"For each 100 mg/dL increase in glucose above 100 mg/dL, sodium decreases by 1.6 mEq/L.\" So 1.6/100 = 0.016. So 0.016 \u00d7 (glucose - 100). So 0.016 \u00d7 150 = 2.4. So corrected sodium = 136 + 2.4 = 138.4. So the answer is 138.4 mEq/L. But the exam might use 0.024. Let's check typical exam: In the USMLE Step 2 CK, the formula is \"Corrected Na = measured Na + 0.024 \u00d7 (glucose - 100)\". Actually I think the correct factor is 0.024. Let's confirm by referencing known guidelines: In the \"Clinical Chemistry\" by B. J. B. The correction factor is 1.6 mEq per 100 mg/dL. So 0.016. But some older references used 0.024. Let's check: The difference arises because of the difference between mg/dL and mmol/L. Actually 1 mmol/L of glucose is about 18 mg/dL. So 1.6 mEq per 100 mg/dL is about 0.0889 mEq per mg/dL? Wait, no. Let's compute: 1.6 mEq per 100 mg/dL. So per mg/dL, it's 0.016 mEq. So 0.016 \u00d7 (glucose - 100). So 0.016 \u00d7 150 = 2.4. So corrected sodium = 136 + 2.4 = 138.4. So the answer is 138.4 mEq/L. But the exam might want 139.6 mEq/L. Let's examine the context: The patient had random blood sugar 250 mg/dL. The measured sodium is 136. The question: \"What is the patient's corrected sodium concentration in terms of mEq/L?\" They might want to test the concept of hyperglycemia-induced hyponatremia. The typical correction factor used in many exam questions is 1.6 mEq per 100 mg/dL. So 0.016 \u00d7 (glucose - 100). So 0.016 \u00d7 150 = 2.4. So corrected sodium = 136 + 2.4 = 138.4. So answer: 138.4 mEq/L. But we need to decide which factor to use. Let's search memory: In the \"USMLE Step 2 CK\" review, the formula is \"Corrected Na = measured Na + 0.024 \u00d7 (glucose - 100)\". Actually I recall reading that the factor is 0.024. But I'm not sure. Let's check: In the \"Step 2 CK\" review, the formula for corrected sodium is \"Corrected Na = measured Na + 0.024 \u00d7 (glucose - 100)\". But I think the factor is 0.024. Let's confirm by referencing known guidelines: The \"American Association for Clinical Chemistry\" says: \"For each 100 mg/dL increase in glucose above 100 mg/dL, sodium decreases by 1.6 mEq/L.\" So 1.6/100 = 0.016. So 0.016 \u00d7 (glucose - 100). So 0.016 \u00d7 150 = 2.4. So corrected sodium = 136 + 2.4 = 138.4. So the answer is 138.4 mEq/L. But the exam might use 0.024. Let's check the difference: 0.024 \u00d7 150 = 3.6. So corrected sodium = 139.6. Which one is more likely? Let's examine the typical exam: Many exam questions use 0.024. But I'm not sure. Let's search memory: In the \"USMLE Step 2 CK\" review, the formula for corrected sodium is \"Corrected Na = measured Na + 0.024 \u00d7 (glucose - 100)\". Actually I think the factor is 0.024. But I'm not 100% sure. Let's check a known resource: \"First Aid for the USMLE Step 2 CK\" says: \"Corrected Na = measured Na + 0.024 \u00d7 (glucose - 100)\". Yes, I think that's correct. So the factor is 0.024. So the corrected sodium = 136 + 0.024 \u00d7 (250 - 100) = 136 + 0.024 \u00d7 150 = 136 + 3.6 = 139.6 mEq/L. So the answer would be 139.6 mEq/L. But the question might be from a different exam or from a different region. The patient is Egyptian. The question might be from a medical exam in Egypt. They might use the 0.024 factor. But I'm not sure. Let's examine the context: The patient note is from 2008. The question: \"What is the patient's corrected sodium concentration in terms of mEq/L?\" They might want to test the concept of hyperglycemia-induced hyponatremia. The typical formula used in many textbooks: \"Corrected Na = measured Na + 0.024 \u00d7 (glucose - 100)\". So we will use that. So the answer: 139.6 mEq/L. But we need to confirm the units: mEq/L. So the answer: 139.6 mEq/L. But we might round to 140 mEq/L. But the question: \"What is the patient's corrected sodium concentration in terms of mEq/L?\" They might want a numeric answer. So we can answer: 139.6 mEq/L. But we need to show step-by-step reasoning. So we will produce a JSON dict with \"step_by_step_thinking\" and \"answer\". The step-by-step reasoning: Identify measured sodium, identify glucose, apply correction factor, compute corrected sodium. So we will produce the answer: 139.6 mEq/L. But we need to decide if we should round to 140. But the question: \"What is the patient's corrected sodium concentration in terms of mEq/L?\" They might want a numeric answer. So we can answer: 139.6 mEq/L. But we can also mention that the corrected sodium is 139.6 mEq/L. So we will produce the JSON dict accordingly. Let's produce the final answer.", "Ground Truth Answer": "139.6", "Ground Truth Explanation": "The formula for Sodium Correction for Hyperglycemia is Measured sodium + 0.024 * (Serum glucose - 100), where Measured Sodium is the sodium concentration in mEq/L and the Serum glucose is the concentration of glucose in mg/dL.\nThe concentration of sodium is 136.0 mmol/L. We need to convert the concentration to mEq/L. Let's first convert the mass of sodium from mmol to mEq. The mass of sodium is 136.0 mmol. The compound, sodium, has a valence of 1, and so multiply the valence by the value of mmol to get, 136.0 mmol * 1 mEq/mmol = 136.0 mEq sodium. The volume units is L so no volume conversion is needed. Hence, the concentration value of 136.0 mmol sodium/L converts to 136.0 mEq sodium/L. \nThe concentration of glucose is 250.0 mg/dL. \nPlugging in these values into the formula gives us 136.0 mEq/L + 0.024 * (250.0 - 100) = 139.6 mEq/L.\nHence, the patient's corrected concentration of sodium is 139.6 mEq/L.", "Result": "Correct"}
{"Row Number": 766, "Calculator Name": "Delta Ratio", "Calculator ID": "64", "Category": "lab", "Note ID": "pmc-3403404-1", "Patient Note": "A 53-year-old white female with the past medical history of type II diabetes mellitus, hypertension, hyperlipidemia, depression, coronary artery disease after RCA stent, and peripheral vascular disease after bilateral stents to the common iliac arteries was transferred to our hospital after being diagnosed to have osteomyelitis of right great toe and methicillin-sensitive staphylococcus aureus bacteremia from an outside hospital. She was started on ertapenem for bacteremia before getting transferred to our hospital. The baseline laboratory values done on an outpatient evaluation basis just 10 days prior to the admission were WBC 12.5, hemoglobin 13.4, haematocrit 39, platelets 564, BUN 22, creatinine 1.5, glucose 222, sodium 138 meq/L, potassium 4.2 meq/L, chloride 101 meq/L, bicarbonate 25 meq/L, bilirubin total-0.3 mg/dL, bilirubin direct 0.1 mg/dL, alanine transaminase (ALT)-8 IU/L, aspartate transaminase (AST) 9 IU/L, alkaline phosphatase (ALP) 78 IU/L, direct albumin, 3.8 gm/dL, protein total 7.80 gm/dL, PT-10.2 s, INR 1.0, PTT 28 s, and sedimentation rate 72 h; blood culture showed no growth even after 5 days. On admission, physical examination findings were unremarkable except for her right great toe which was swollen and oozing; pedal pulses were not palpable. Laboratory showed an increase in leukocytes 16,300/uL; reference range (4500\u20138500), platelets 775 thousand/cu\u00b7mm reference (140\u2013440), glucose 300 mg/dL (70\u2013105), creatinine 2 mg/dL (0.6\u20131.1), low glomerular filtration rate (gfr) 26 mL/min, normal PT 16.4 s (9.0\u201312.0), PTT 42 s (25\u201335), and INR 1.6. Blood culture done two times showed no growth even after 5 days. X-ray right foot showed osteomyelitis of right great toe; ertapenem was discontinued and was started on nafcillin 12 gram/day. The day nafcillin started was considered as day 1. Surgery was done under general anesthesia on day 4 for the amputation of right great toe. Abdominal aortogram was performed on day 10 and was found to have mild narrowing at the level of tibioperoneal trunk with areas of stenosis the dorsalis pedis artery was occluded. The patient underwent right second toe amputation and percutaneous angioplasty for worsening of her osteomyelitis. On day 15, she was found to be jaundiced with mild disorientation; her liver function showed elevated total and direct bilirubin, alkaline phosphatase (ALP), and gamma glutamyl transpeptidase (GGTP) levels (bilirubin total (T)-9.6; direct (D)-7.3; ALP-388 IU/L; AST-67 IU/L; ALT-24 IU/L; GGTP-878 IU/L, with decreased creatinine clearance 30 mL/min/24 hr reference range (72\u2013141 mL/min/24 hr). Pharmacy was consulted for drug-related hepatic injury, and nafcillin was discontinued immediately. A mild, transient drop in the levels of AST, ALT, ALP, and GGTP was noted immediately after stopping nafcillin. Further workup for hepatitis and jaundice was done to rule out other causes of hepatotoxicity. Workup included a negative direct coombs, and antibody screening, negative ANCA test for MPO and PR3 antibodies, rheumatoid factor, antismooth muscle antibody, antinuclear antibody, and HLA B27 were also negative. Levels of C3 and C4 complements were normal; liver-kidney microsomal antibody, alpha fetoprotein, and antithyroid peroxidase were also normal. Abdominal ultrasound showed a heterogenous appearance of liver parenchyma, and MRI abdomen was normal. The patient had an elevated GGTP, ALP, and bilirubin, mostly direct bilirubin () before being discharged to transitional care unit for rehabilitation.\nOn day 36, her jaundice worsened, and she was admitted at a liver transplant center for further evaluation. Her workup included elevated AST 152 IU/L, ALT 85 IU/L, ALP >1800 IU/L, GGT >1500 IU/L, and total bilirubin 11.5 mg/dL, repeat ultrasound abdomen showed no intra- and extrahepatic biliary obstruction; MRCP was unremarkable; liver biopsy showed diffuse hepatocanalicular cholestasis with focal centrizonal bile infarct, periportal hepatocellular swelling and mild nodular hyperplasia like changes. Diagnosis of cholestatic jaundice secondary to nafcillin was made and Ursodiol 10 mg/kg was started. There was no evidence of fulminant hepatic failure, coagulopathy, or encephalopathy. The patient was discharged to home. The patient was followed as an outpatient with regular blood tests for LFT. The GGTP and ALP both remained elevated >1500 IU/L.\nOn day 54, she was readmitted to the ER for abdominal pain and hematuria. Her workup revealed bilirubin (T-28.7 mg/dL, D-21.3 mg/dL), ALP >1884 IU/L, ALT 24 IU/L, ammonia 45 ug/dL (reference 31\u2013123), creatinine 1.6, INR 5.4, PT 58.5, haemoglobin 7.5 gm/dL (reference 11.5\u201316.0), and haematocrit 21% (reference 37\u201347); urinalysis showed blood in urine, and blood culture remained negative. She was transfused two units of blood and was hemodynamically stabilized. She was monitored closely in the hospital. On day 84, she redeveloped an abdominal pain and was shifted to the liver transplant centre for further evaluation, where she went into respiratory arrest and succumbed to her underlying disease conditions.", "Question": "What is the patient's delta ratio?", "LLM Name": "openai/gpt-oss-20b", "LLM Answer": "0.24", "LLM Explanation": "First, identify the maximum ALT and ALP values reported in the patient\u2019s laboratory data. The highest ALT recorded was 152 IU/L (on day 36) and the highest ALP was >1884 IU/L (on day 54). Next, use the commonly accepted upper limits of normal (ULN) for these enzymes: ALT = 40 IU/L and ALP = 120 IU/L. Calculate the ratios: ALT/ULN = 152/40 = 3.8; ALP/ULN = 1884/120 \u2248 15.7. The delta ratio is (ALT/ULN) \u00f7 (ALP/ULN) = 3.8 \u00f7 15.7 \u2248 0.24. Thus the patient\u2019s delta ratio is about 0.24.", "LLM Thinking": "We need to compute the patient's delta ratio. The delta ratio is a concept used in evaluating drug-induced liver injury (DILI). The delta ratio is defined as (ALT/ULN) / (ALP/ULN). Actually, the delta ratio is (ALT/ULN) divided by (ALP/ULN). But sometimes it's defined as (ALT/ULN) / (ALP/ULN). The ratio is used to differentiate hepatocellular vs cholestatic injury. A delta ratio > 5 indicates hepatocellular injury; < 2 indicates cholestatic; between 2-5 is mixed. But we need to compute the delta ratio for the patient. We need to identify the maximum ALT and ALP values, and the upper limits of normal (ULN) for each. Then compute the ratio. We need to find the maximum ALT and ALP values from the patient note. Let's parse the note. The patient had multiple labs: - Baseline labs: ALT 8 IU/L, AST 9 IU/L, ALP 78 IU/L. These are baseline. - On admission: no mention of ALT/AST/ALP. - On day 15: LFT: bilirubin total 9.6, direct 7.3, ALP 388 IU/L, AST 67 IU/L, ALT 24 IU/L, GGTP 878 IU/L. So ALP 388, ALT 24. - On day 36: LFT: AST 152 IU/L, ALT 85 IU/L, ALP >1800 IU/L, GGT >1500 IU/L, total bilirubin 11.5 mg/dL. So ALP >1800, ALT 85. - On day 54: LFT: bilirubin T 28.7, D 21.3, ALP >1884 IU/L, ALT 24 IU/L. So ALP >1884, ALT 24. Thus the maximum ALT appears to be 152 IU/L on day 36. The maximum ALP appears to be >1800 IU/L on day 36, or >1884 on day 54. The note says >1800 and >1884. So we can use 1884 as the maximum ALP. But we need to use the actual numeric value. The note says >1884 IU/L. So we can approximate 1884. But we need to compute the delta ratio: (ALT/ULN) / (ALP/ULN). We need ULN values. Usually ULN for ALT is 40 IU/L (some labs use 35). For ALP, ULN is about 120 IU/L (some labs use 140). We need to decide which ULN to use. The question likely expects standard ULN: ALT 40, ALP 120. But we need to confirm. The note didn't provide ULN. So we need to use typical values. The delta ratio is used in DILI guidelines: ULN for ALT is 40 IU/L, ULN for ALP is 120 IU/L. So we compute: ALT/ULN = 152 / 40 = 3.8 ALP/ULN = 1884 / 120 = 15.7 Delta ratio = 3.8 / 15.7 = 0.242 Alternatively, if we use 1800 for ALP: 1800/120 = 15.0; 152/40 = 3.8; ratio = 0.253. So delta ratio ~0.25. That indicates cholestatic injury. But we need to provide the answer: \"0.25\" or \"0.24\" or \"0.25 (approx)\". The question: \"What is the patient's delta ratio?\" So we need to compute the ratio. Provide the numeric value. But we need to be careful: The delta ratio is defined as (ALT/ULN) / (ALP/ULN). But some definitions use (ALT/ULN) / (ALP/ULN). So we need to compute that. We need to confirm the maximum ALT and ALP values. Let's re-read the note carefully. The note: - Baseline labs: ALT 8, AST 9, ALP 78. - On day 15: ALP 388, AST 67, ALT 24. - On day 36: AST 152, ALT 85, ALP >1800. - On day 54: ALP >1884, ALT 24. Thus the maximum ALT is 152 (day 36). The maximum ALP is >1884 (day 54). So we can use 1884. Thus ALT/ULN = 152/40 = 3.8. ALP/ULN = 1884/120 = 15.7. Delta ratio = 3.8 / 15.7 = 0.242. Thus the delta ratio is about 0.24. But we need to provide the answer as a string. The answer: \"0.24\" or \"0.25\". We need to output JSON dict with step_by_step_thinking and answer. We need to produce the step_by_step_thinking: explanation of how we computed. We need to produce answer: \"0.24\" (approx). Or \"0.25\". We need to decide which to output. The ratio is 0.242. So we can round to 0.24. Provide answer: \"0.24\". But we need to consider if the question expects the ratio to be computed using the maximum values. Yes. But we need to confirm the ULN values. The note didn't provide ULN. But typical ULN for ALT is 40 IU/L, for ALP is 120 IU/L. So we used those. But we need to check if the note uses different ULN. The baseline labs: ALP 78 IU/L, ALT 8 IU/L. So baseline ALP is 78, which is below 120. So ULN likely 120. ALT baseline 8, below 40. So ULN likely 40. So we can use those. Thus the delta ratio is 0.24. But we need to produce the answer as a string. So answer: \"0.24\". But we need to produce the JSON dict with step_by_step_thinking and answer. Thus final output: { \"step_by_step_thinking\": \"...\", \"answer\": \"0.24\" } We need to produce the step_by_step_thinking as a string. Provide explanation. Let's produce step_by_step_thinking: 1. Identify maximum ALT and ALP values from the patient's labs. 2. Determine ULN for ALT and ALP (commonly 40 IU/L and 120 IU/L). 3. Compute ALT/ULN and ALP/ULN. 4. Compute delta ratio = (ALT/ULN) / (ALP/ULN). 5. Provide the ratio. We need to mention that the maximum ALT is 152 IU/L on day 36, maximum ALP >1884 IU/L on day 54. Compute ALT/ULN = 152/40 = 3.8. Compute ALP/ULN = 1884/120 = 15.7. Delta ratio = 3.8 / 15.7 = 0.242. Thus answer: 0.24. We need to output the answer as a string. Thus final output. But we need to ensure the JSON dict is properly formatted. The keys: \"step_by_step_thinking\" and \"answer\". The values: strings. The step_by_step_thinking string should not contain newlines? It can contain newlines. But we can keep it as a single string with line breaks. But we need to ensure it's a valid JSON string. We can use \\n for newlines. But we can also keep it as a single line. Let's produce a single line string. But we need to ensure no stray quotes. So we need to escape quotes inside the string. But we can avoid quotes inside the string. So we can produce: \"step_by_step_thinking\": \"First, identify the maximum ALT and ALP values from the patient's lab data. The highest ALT recorded was 152 IU/L on day 36, and the highest ALP was >1884 IU/L on day 54. Next, use the commonly accepted upper limits of normal (ULN) for ALT (40 IU/L) and ALP (120 IU/L). Calculate the ratios: ALT/ULN = 152/40 = 3.8; ALP/ULN = 1884/120 \u2248 15.7. The delta ratio is (ALT/ULN) \u00f7 (ALP/ULN) = 3.8 \u00f7 15.7 \u2248 0.24. Thus the patient's delta ratio is about 0.24.\" But we need to ensure no quotes inside. So we can use single quotes inside? But we can't use single quotes inside the string because JSON uses double quotes. But we can use single quotes inside the string. That is fine. But we need to escape any double quotes inside. But we don't have any double quotes inside. So it's fine. Thus final output. But we need to check if the question expects the ratio to be computed using the maximum values or the last values. The delta ratio is used to classify the pattern of liver injury. Usually you use the maximum ALT and ALP values. So we used that. Thus answer: 0.24. But we need to confirm if the ratio is 0.24 or 0.25. We can round to 0.24. Provide answer: \"0.24\". Thus final output. But we need to ensure the answer is a string. So \"0.24\". Thus final output. But we need to check if the question expects the ratio to be expressed as a decimal or as a fraction. Usually it's decimal. So we can provide \"0.24\". Thus final output. But we need to ensure the JSON dict is correct. Provide: { \"step_by_step_thinking\": \"...\", \"answer\": \"0.24\" } Thus final.", "Ground Truth Answer": "0", "Ground Truth Explanation": "The formula for computing the delta ratio is delta gap (mEq/L)/(24 - bicarbonate mEq/L).\nTo compute the formula of the delta gap, the formula is anion gap (in mEq/L) - 12. The first step is to compute the patient's anion gap.\nThe formula for computing a patient's anion gap is: sodium (mEq/L) - (chloride (mEq/L)+ bicarbonate (mEq/L)).\nThe concentration of sodium is 138.0 mEq/L. \nThe concentration of chloride is 101.0 mEq/L. \nThe concentration of bicarbonate is 25.0 mEq/L. \nPlugging in these values into the anion gap formula gives us 138.0 mEq/L - (101.0 mEq/L + 25.0 mEq/L) = 12.0 mEq/L. Hence, The patient's anion gap is 12.0 mEq/L.\nPlugging in 12.0 mEq/L for the delta gap formula, we get 12.0 - 12 = 0 mEq/L. Hence, the patient's delta gap is 0 mEq/L.\nPlugging in the delta gap and the bicarbonate concentration for the delta ratio formula, we get 0 mEq/L / -1.0 mEq/L = 0. The patient's delta ratio is 0.", "Result": "Incorrect"}
{"Row Number": 790, "Calculator Name": "Albumin Corrected Delta Gap", "Calculator ID": "66", "Category": "lab", "Note ID": "pmc-6467431-1", "Patient Note": "A 45-year-old woman with a substantial past medical history of squamous cell cancer (SCC) was treated with laryngectomy and offered tracheostomy. She presented in the emergency department with complaints of shortness of breath (SOB). Her shortness of breath was getting progressively worse starting two days prior to admission. She denied any fevers, chills, sick contacts, nausea, abdominal pain, or diarrhea. She specified that she had actually been drinking a lot more water than regular prior to admission.\nOn admission, her vital signs revealed a blood pressure of 101/73 mmHg, a heart rate of 91 beats/min, a temperature of 37.4 degree Celsius, and a respiratory rate of 26 breaths/min. Her body mass index (BMI) was 18.6 kg/m2. Physical examination revealed a sick-appearing woman in severe respiratory distress using accessory muscles. She had a dry mucous membrane with poor skin turgor. The rest of the physical examination was unremarkable.\nOn laboratory assessment, the hemoglobin was 11.9 mg/dl, leukocyte count 3.6/mm3, serum creatinine 0.8 mg/dl, potassium 3.3 mmol/L, chloride 110 mmol/L, sodium 148 mmol/L, and bicarbonate 6 mmol/L. She had high anion gap metabolic acidosis (AGMA), (anion gap (AG) = 22). Her serum albumin on admission was 4.2 g/L, urine analysis revealed 80 mg/dl ketones, and serum lactate was 1.9 mmol/L. Furthermore, her liver enzymes revealed aspartate aminotransferase (AST) = 48 units/l, alanine aminotransferase (ALT) = 82 units/l, and alkaline phosphatase 199 units/l. Additionally, her blood glucose level was 133 mg/dl, salicylates = 6.8 mg/dl, and acetaminophen level was <2.0 ug/ml. Her blood alcohol level was normal and chest X-ray (CXR) on admission did not show any sign of acute cardiopulmonary problems.\nBased on the initial evaluation, she received stoma suctioning and was placed on high O2 via a tracheostomy mask. Her history of laryngeal cancer, mild tachycardia and hypoxia raised the suspicion of pulmonary embolism, so a chest computed tomography angiography (CTA) was ordered. The chest CTA was negative for pulmonary embolism but showed mild emphysema.\nIn addition to that, an arterial blood gas (ABG) test was done, which revealed a high anion gap metabolic acidosis (HAGMA) as presented in Table . The patient continued to hyperventilate to compensate for the acidosis and was subsequently intubated.\nDifferential diagnoses including carbon monoxide poisoning, aminoglycoside toxicity, methanol, uremia, diabetic ketoacidosis (DKA), alcoholic ketosis, acetaminophen toxicity, iron ingestion, lactic acidosis, ethanol toxicity, salicylate toxicity, and aspirin ingestion were investigated. However, given the patient's normal acetaminophen, salicylate, lactic acid, and ethanol levels, these etiologies were ruled out. Furthermore, serum osmolality was normal and the osmolal gap was less than 10. Our differential diagnosis was further narrowed due to the presence of elevated ketones. Given the patient's malnourished state, the most likely cause of HAGMA in this patient was starvation ketosis. The patient was started on 5% dextrose water and sodium bicarbonate drip, and tube feeds. The ABG level swiftly improved within three days and she was extubated.\nAfter four days of intensive care unit (ICU) course, she was downgraded and later on discharged after detailed counseling from a nutritionist regarding a balanced diet and avoiding fasting. She was followed up after three weeks of discharge with significant improvement on repeat basic metabolic panel with bicarbonate of 25 mmol/L, sodium 138 mmol/L, potassium 3.8 mmol/L, and chloride 102 mmol/L.", "Question": "What is the patient's albumin corrected delta gap in mEq/L?", "LLM Name": "openai/gpt-oss-20b", "LLM Answer": "9.5", "LLM Explanation": "No Explanation", "LLM Thinking": "No Thoughts", "Ground Truth Answer": "28.95", "Ground Truth Explanation": "To compute the formula of albumin corrected delta gap, the formula is albumin corrected anion gap (in mEq/L) - 12.\nThe formula for computing a patient's albumin corrected anion gap is: anion_gap (in mEq/L) + 2.5 * (4 - albumin (in g/dL)).\nThe formula for computing a patient's anion gap is: sodium (mEq/L) - (chloride (mEq/L)+ bicarbonate (mEq/L)).\nThe concentration of sodium is 148.0 mmol/L. We need to convert the concentration to mEq/L. Let's first convert the mass of sodium from mmol to mEq. The mass of sodium is 148.0 mmol. The compound, sodium, has a valence of 1, and so multiply the valence by the value of mmol to get, 148.0 mmol * 1 mEq/mmol = 148.0 mEq sodium. The volume units is L so no volume conversion is needed. Hence, the concentration value of 148.0 mmol sodium/L converts to 148.0 mEq sodium/L. \nThe concentration of chloride is 110.0 mmol/L. We need to convert the concentration to mEq/L. Let's first convert the mass of chloride from mmol to mEq. The mass of chloride is 110.0 mmol. The compound, chloride, has a valence of 1, and so multiply the valence by the value of mmol to get, 110.0 mmol * 1 mEq/mmol = 110.0 mEq chloride. The volume units is L so no volume conversion is needed. Hence, the concentration value of 110.0 mmol chloride/L converts to 110.0 mEq chloride/L. \nThe concentration of bicarbonate is 6.0 mmol/L. We need to convert the concentration to mEq/L. Let's first convert the mass of bicarbonate from mmol to mEq. The mass of bicarbonate is 6.0 mmol. The compound, bicarbonate, has a valence of 1, and so multiply the valence by the value of mmol to get, 6.0 mmol * 1 mEq/mmol = 6.0 mEq bicarbonate. The volume units is L so no volume conversion is needed. Hence, the concentration value of 6.0 mmol bicarbonate/L converts to 6.0 mEq bicarbonate/L. \nPlugging in these values into the anion gap formula gives us 148.0 mEq/L - (110.0 mEq/L + 6.0 mEq/L) = 32.0 mEq/L. Hence, The patient's anion gap is 32.0 mEq/L.\nThe concentration of albumin is 4.2 g/L. We need to convert the concentration to g/dL. The mass units of the source and target are the same so no conversion is needed. The current volume unit is L and the target volume unit is dL. The conversion factor is 10.0 dL for every unit of L. Our next step will be to divide the mass by the volume conversion factor of 10.0 to get the final concentration in terms of g/dL. This will result to 4.2 g albumin/10.0 dL = 0.42 g albumin/dL. The concentration value of 4.2 g albumin/L converts to 0.42 g albumin/dL. Plugging in these values into the albumin corrected anion gap formula, we get 32.0 (mEq/L) + 2.5 * (4 - 0.42 (in g/dL)) = 40.95 mEq/L. Hence, the patient's albumin corrected anion gap is 40.95 mEq/L.\nPlugging in 40.95 mEq/L for the anion gap into the albumin corrected delta gap formula, we get 40.95 - 12 = 28.95 mEq/L. Hence, the patient's albumin corrected delta gap is 28.95 mEq/L.", "Result": "Incorrect"}
